# Chapter 108: Inhalant Intoxication

## The Biological and Neurological Basis of Inhalant Intoxication

### Introduction

Inhalant intoxication represents a transient and complex neuropsychiatric syndrome resulting from the deliberate inhalation of volatile substances for the purpose of achieving an altered state of consciousness (Sharp et al., 2008; Daley & Douaihy, 2019). As a substance-induced disorder, it is characterized by clinically significant disturbances in consciousness, cognition, perception, affect, or behavior that manifest during or shortly after the administration of the substance (Sarkar et al., 2023; ICD-10, cited in Sarkar et al., 2023). The substances abused are a heterogeneous group of volatile chemicals found in a wide range of common household and industrial products, including toluene, butane, nitrous oxide, gasoline mixtures, various chlorocarbons like trichloroethylene, and fluorocarbons (Sharp et al., 2008; Abou‐Donia, 2015). This heterogeneity presents a significant challenge to developing a unified biological model of intoxication, as the specific pharmacological actions can vary considerably between different chemical classes (Sharp et al., 2008; Winbigler & Chyka, 2022).

From a biological perspective, inhalant intoxication can be conceptualized as an acute toxic encephalopathy, a diffuse disease of the brain that alters its function or structure (Unknown, 2019). The clinical presentation is often nonspecific, mimicking a wide array of other medical and psychiatric conditions, which complicates diagnosis (Ciszowski & Mietka-Ciszowska, 2013). The acute symptomatology frequently includes dizziness, disorientation, ataxia, slurred speech, and headache, which can progress to more severe states of belligerence, irritability, and delirium (Sharp et al., 2008). This clinical picture aligns with the cardinal features of delirium, an acute confusional state marked by disturbances in attention, consciousness, and cognition with a fluctuating course (Schildkrout, 2014; Todd & Teale, 2017; Lipowski, 1987). In severe cases, the intoxication can lead to stupor, coma, seizures, respiratory depression, and death (Sharp et al., 2008; Tiscione & Rohrig, 2021; Isbell, 1956).

Chronic use of inhalants is associated with a strong psychological dependence and a weaker, though present, physical dependence, often accompanied by a wide range of comorbid psychiatric disorders (Sharp et al., 2008; Daley & Douaihy, 2019). The long-term neurological consequences are profound and can include significant cognitive dysfunction, cerebellar signs such as limb dysmetria, hearing loss, and peripheral neuropathies (Sharp et al., 2008; Brust, 2002). Many of these chronic effects are believed to stem from the direct neurotoxic properties of the inhaled solvents, which can cause irreversible brain damage, particularly to the white matter (Knox & Nelson, 1966; Borne et al., 2005; Matsuoka, 2007). This chapter will provide a comprehensive overview of the biological and neurological mechanisms underlying inhalant intoxication, drawing upon evidence from analogous substance use disorders and toxic exposures to synthesize a current understanding of this complex and damaging form of substance abuse. We will explore the neuropharmacological actions of these substances, their impact on neural circuits and brain structures, the genetic and developmental factors influencing vulnerability, and the biological rationale for potential treatment strategies.

### Neurobiological Systems

The acute psychoactive effects and chronic neurotoxicity of inhalants are mediated through their interactions with multiple neurobiological systems. While the precise mechanisms for every individual solvent are not fully elucidated, general principles can be extrapolated from their chemical properties and from the study of other central nervous system (CNS) depressants and stimulants (Abou‐Donia, 2015; Brust, 1999). Inhalants are highly lipid-soluble, allowing them to rapidly cross the blood-brain barrier and interfere with neuronal membrane function and neurotransmission (Tiscione & Rohrig, 2021; Alfonso‐Loeches & Guerri, 2011).

#### Neurotransmitter Systems and Neuropharmacology

The behavioral effects of inhalant intoxication, which include euphoria, disinhibition, and altered perception, are rooted in the disruption of major neurotransmitter systems (Sharp et al., 2008; Gaskill, 1945). Like most drugs of abuse, inhalants are believed to significantly modulate the brain's reward pathways, particularly the mesocorticolimbic dopamine system (Hayes & Lingford‐Hughes, 2023; Spanagel et al., 2016). The reinforcing effects and the compulsive drug-seeking behavior characteristic of addiction are strongly linked to enhanced dopamine release in structures like the nucleus accumbens (Kalivas et al., 2003; Antonio & Alfredo, 2012). While direct evidence for inhalants is limited, the euphoria and stimulant-like effects (e.g., excitement) seen with some solvents suggest an interaction with dopaminergic and noradrenergic pathways, similar to substances like cocaine and amphetamines (Graddy & Rastegar, 2025; Varı̀ et al., 2018; Krishnan, 2024). This dopaminergic hyperactivity may also underlie the development of paranoid ideation and psychotic symptoms that can occur during acute intoxication or with chronic use (Dore & Sweeting, 2006; Mauri, 2016; Seeman & Seeman, 2011).

Many volatile solvents possess CNS depressant properties, producing effects such as ataxia, slurred speech, sedation, and, at high doses, stupor and coma (Sharp et al., 2008; Tiscione & Rohrig, 2021). These effects strongly suggest modulation of the gamma-aminobutyric acid (GABA) system, the primary inhibitory neurotransmitter system in the CNS (Tseng et al., 2020). Similar to alcohol, barbiturates, and benzodiazepines, many inhalants are thought to enhance GABAergic transmission, likely by acting on GABA-A receptors (Becker & Redmond, 2002; Isbell, 1956; Tseng et al., 2020). This enhanced inhibition would account for the anxiolytic, sedative, and motor-incoordinating effects of intoxication (Fingerhood, 2020). The development of tolerance and a withdrawal syndrome characterized by CNS hyperexcitability (e.g., anxiety, tremors, seizures) upon cessation of chronic use further points to neuroadaptive changes in the GABA system, a phenomenon well-documented for other CNS depressants (Becker, 1998; Trevisan et al., 1998; Hollister, 1977).

The excitatory glutamate system, particularly N-methyl-D-aspartate (NMDA) receptors, is another critical target. Many anesthetic and dissociative drugs, such as ketamine, act as NMDA receptor antagonists (Andrade, 2017; Rastegar & Fingerhood, 2015). Some inhalants may share this mechanism, contributing to cognitive impairment, amnesia, and a sense of detachment or dissociation (Sharp et al., 2008; Good, 1989). Chronic exposure to NMDA antagonists can lead to upregulation of these receptors, which contributes to withdrawal hyperexcitability and seizures (Becker & Redmond, 2002; Trujillo, 2002). Furthermore, excessive glutamate activity (excitotoxicity) is a key mechanism of neuronal damage following hypoxic-ischemic insults, which can occur during inhalant overdose (Pujol & Puel, 1999; Aydın et al., 2015). This excitotoxic cascade may contribute to the irreversible brain damage seen in chronic abusers (Virmani et al., 2010).

The serotonergic system, which is crucial for regulating mood, perception, and sleep, is also likely affected (Scotton et al., 2019). The hallucinogenic or psychedelic properties of some inhalants may be mediated through actions at serotonin receptors, particularly the 5-HT2A subtype, similar to classic hallucinogens like LSD (Pechnick et al., 2014; Iversen et al., 2009). The mood disturbances, anxiety, and sleep problems associated with both acute intoxication and withdrawal from inhalants also point to a dysregulation of serotonin pathways (Sharp et al., 2008; Chouinard & Chouinard, 2015). The complex interplay between these neurotransmitter systems—dopamine, GABA, glutamate, and serotonin—underlies the multifaceted clinical presentation of inhalant intoxication (Willner, 1984).

#### Brain Regions, Neural Circuits, and Functional Connectivity

Inhalant intoxication produces a global CNS depression punctuated by excitatory phenomena, reflecting widespread effects on multiple brain regions and neural circuits (Winters, 1976). The acute effects of impaired judgment, disinhibition, and emotional lability suggest significant disruption of the prefrontal cortex (PFC), the brain's executive control center (Alfonso‐Loeches & Guerri, 2011). The PFC is crucial for decision-making, impulse control, and regulating social behavior, functions that are clearly compromised during intoxication (Lahey, 2021). Chronic inhalant abuse is associated with deficits in executive function, which may reflect long-term damage to frontal lobe structures (Page, 1983; Golden & Golden, 2004).

The cerebellum is highly sensitive to the toxic effects of solvents, and its dysfunction is a hallmark of both acute and chronic inhalant use (Sharp et al., 2008). Symptoms such as ataxia, unsteady gait, slurred speech (dysarthria), and limb dysmetria directly map onto cerebellar functions of motor coordination and balance (Tiscione & Rohrig, 2021; Sidana et al., 2020). Chronic abuse can lead to demonstrable cerebellar atrophy on neuroimaging, providing a structural basis for these persistent motor deficits (Borne et al., 2005).

The limbic system, including the hippocampus and amygdala, is also profoundly affected. The hippocampus is critical for memory formation, and its impairment by inhalants contributes to the amnesia and learning difficulties experienced during and after intoxication (Page, 1983; Knox & Nelson, 1966). The amygdala, central to processing emotions like fear and anxiety, is likely involved in the mood swings, irritability, and panic reactions that can occur (Sharp et al., 2008; Anisman & Merali, 1999). The disruption of cortico-limbic circuits is thought to be fundamental to the loss of emotional control and the development of addiction (Rowe, 2010; Pontius, 1993).

The basal ganglia, particularly the putamen and globus pallidus, are key nodes in motor control circuits and are also implicated in reward and habit formation. These structures are notably vulnerable to hypoxic-ischemic damage and specific toxins, such as carbon monoxide and methanol (Prajapati et al., 2024; Jain et al., 2013; White, 1960). The parkinsonism and dystonia occasionally seen with inhalant abuse or other toxic exposures suggest dysfunction within these circuits (Prajapati et al., 2024; Dalvi et al., 2012; Messouak et al., 2008). Chronic toluene exposure, for example, has been associated with neuroimaging abnormalities in the basal ganglia (Matsuoka, 2007; Borne et al., 2005).

Finally, brainstem structures, including the reticular activating system, are critical for maintaining consciousness and regulating vital functions like respiration and cardiovascular control (Winters, 1976). The progression from drowsiness to stupor and coma during overdose reflects a dose-dependent depression of these brainstem functions (Tiscione & Rohrig, 2021; Isbell, 1956). Respiratory depression is a primary cause of death in severe inhalant intoxication (Sharp et al., 2008; Tiscione & Rohrig, 2021).

### Genetic and Molecular Basis

The development of inhalant use disorders, like other substance dependencies, is understood to be a complex interplay of environmental, psychological, and biological factors, including a significant genetic component (Daley & Douaihy, 2019; Winters & Ingwalson, 2022). While specific genes for inhalant addiction have not been identified, research into other substance use disorders provides a framework for understanding potential genetic and molecular vulnerabilities (Hughes, 1999). It is plausible that heritable factors contribute to an individual's risk by influencing personality traits, responses to stress, metabolism of xenobiotics, and the sensitivity of neural reward and control circuits (Bramon & Murray, 2001; Leckman et al., 2002).

Family, twin, and adoption studies have consistently shown that substance use disorders, including alcoholism and nicotine dependence, have a substantial heritable component (Hughes & Hatsukami, 1987; Winters & Ingwalson, 2022). This suggests that genetic variations can predispose individuals to the reinforcing effects of drugs or make them more susceptible to losing control over their use (Marconi et al., 1967; Isbell & Fraser, 1950). For example, genetic polymorphisms in genes encoding dopamine receptors or transporters could alter the functioning of the brain's reward system, making the euphoric effects of substances more pronounced for some individuals (Wenbing et al., 2025; Spanagel et al., 2016). Similarly, variations in genes related to the serotonin or GABA systems could influence traits like impulsivity, anxiety, or stress reactivity, which are known risk factors for developing addiction (Batinić et al., 2017; Anisman & Merali, 1999).

Genetic factors also play a critical role in the metabolism of volatile organic compounds. The cytochrome P450 (CYP) family of enzymes in the liver is responsible for the biotransformation of many solvents (Toffoletto et al., 2007). Genetic polymorphisms in CYP genes are well-documented and lead to significant interindividual differences in enzyme activity, categorizing individuals as poor, intermediate, extensive, or ultrarapid metabolizers (Gram et al., 1993; Shah, 2005). Such variations could influence both the psychoactive effects and the toxicity of inhaled substances. For example, an individual who metabolizes a solvent slowly might experience more prolonged and intense intoxication from a given exposure, potentially increasing its reinforcing properties (Gram et al., 1993). Conversely, rapid metabolism could lead to a faster accumulation of toxic metabolites, increasing the risk of organ damage, such as hepatotoxicity or nephrotoxicity (Pendergraft et al., 2014; Toffoletto et al., 2007).

At the molecular level, chronic drug exposure induces lasting changes in gene expression within brain reward circuits, a process known as neuroplasticity (Kalivas et al., 2003). These changes are thought to underlie the transition from voluntary drug use to compulsive addiction (Hayes & Lingford‐Hughes, 2023; Stewart, 2003). Transcription factors like ΔFosB and CREB (cAMP response element-binding protein) are key molecular switches that are activated by repeated drug administration and, in turn, regulate the expression of numerous other genes (Antonio & Alfredo, 2012). This cascade of gene expression changes leads to structural and functional alterations in neurons, such as changes in dendritic spine density and receptor sensitivity, which strengthen the neural pathways driving drug-seeking behavior and contribute to tolerance and withdrawal phenomena (Kalivas et al., 2003; Trujillo, 2002). While this has been studied extensively for drugs like cocaine and opiates, it is highly probable that similar molecular adaptations occur in response to chronic inhalant abuse, contributing to the persistent nature of the addiction (Kalivas, 2003).

Furthermore, there is significant comorbidity between substance use disorders and other psychiatric illnesses like schizophrenia and mood disorders, which also have strong genetic underpinnings (Buckley, 2007; Keith, 2007). It is hypothesized that shared genetic vulnerabilities may predispose individuals to both addiction and other mental illnesses (Bramon & Murray, 2001). For instance, genes affecting dopamine regulation might increase the risk for both psychosis and stimulant abuse (Sklar et al., 2011). Inhalant abuse, by inducing neurotoxic or neuroinflammatory changes, could act as an environmental "hit" that unmasks a latent genetic vulnerability for a psychiatric disorder in susceptible individuals (Sommer & Arango, 2017; McCarty, 2020).

### Brain Structure and Function

The profound neurological and psychiatric symptoms of inhalant intoxication and chronic abuse are underpinned by significant alterations in brain structure and function. Neuroimaging and neuropathological studies, particularly those involving chronic exposure to solvents like toluene, provide compelling evidence of widespread and often irreversible damage to the central nervous system (Sharp et al., 2008; Brust, 2002).

#### Neuroimaging and Neuroanatomical Findings

One of the most consistent findings in chronic inhalant abusers is toxic leukoencephalopathy, a disorder of the brain's white matter (Sanaei‐Zadeh, 2016; Borne et al., 2005). Volatile solvents are highly lipophilic, giving them a strong affinity for myelin, the lipid-rich sheath that insulates nerve axons and facilitates rapid electrical signaling (Matsuoka, 2007). Chronic exposure leads to demyelination and delayed apoptosis of oligodendrocytes, the cells that produce myelin (Prajapati et al., 2024). On magnetic resonance imaging (MRI), this damage manifests as diffuse, symmetrical hyperintensities in the cerebral white matter on T2-weighted sequences, often with a particular predilection for the periventricular and subcortical regions (Prajapati et al., 2024; Shprecher & Mehta, 2010). This pattern is strikingly similar to that seen in delayed post-hypoxic leukoencephalopathy following carbon monoxide poisoning, another condition involving a toxic insult to the brain (Prajapati et al., 2024; Satake et al., 2024). This widespread white matter pathology disrupts the structural and functional connectivity between different brain regions, providing a clear anatomical basis for the global cognitive impairment, slowed information processing, and attentional deficits seen in chronic abusers (Knox & Nelson, 1966; Golden & Golden, 2004).

Cerebral and cerebellar atrophy are also common findings (Borne et al., 2005; Page, 1983). This generalized loss of brain volume is visible on both CT and MRI scans and reflects widespread neuronal loss resulting from direct neurotoxicity, excitotoxicity, or repeated hypoxic-ischemic insults during episodes of overdose (Knox & Nelson, 1966; Virmani et al., 2010). Cerebellar atrophy is particularly prominent and correlates clinically with the persistent ataxia, dysmetria, and gait disturbances that characterize the "huffer's neuropathy" (Sharp et al., 2008; Sidana et al., 2020).

In addition to diffuse changes, specific subcortical structures appear to be particularly vulnerable. The basal ganglia (putamen, globus pallidus) and thalamus are regions with high metabolic demand, making them susceptible to hypoxic injury and certain toxins (White, 1960; Jain et al., 2013). Lesions, including necrosis and hemorrhage in these areas, have been reported following acute, severe intoxication with substances like methanol and carbon monoxide, and can result in parkinsonism and dystonia (Jain et al., 2013; Prajapati et al., 2024; Kolbe et al., 1999). Chronic toluene abuse has also been linked to signal abnormalities in the basal ganglia and thalamus (Matsuoka, 2007). Damage to these structures disrupts critical motor and cognitive circuits, contributing to movement disorders and executive dysfunction (Dalvi et al., 2012). The hippocampus, a key structure for memory, is also highly vulnerable to hypoxia and excitotoxicity, and its damage likely contributes to the memory impairments seen in abusers (Calingasan et al., 1996; Page, 1983).

#### Cellular and Synaptic Mechanisms

At the cellular level, inhalants disrupt neuronal function through several mechanisms. Their lipophilic nature allows them to intercalate into neuronal membranes, altering membrane fluidity and the function of embedded proteins such as ion channels and receptors (Alfonso‐Loeches & Guerri, 2011). This can directly interfere with the generation and propagation of action potentials and synaptic transmission.

As discussed previously, inhalants modulate the activity of key neurotransmitter systems. They can enhance inhibitory GABAergic currents and inhibit excitatory NMDA glutamate receptor function, leading to a net depression of CNS activity (Tseng et al., 2020; Becker & Redmond, 2002). Chronic exposure leads to neuroadaptive changes, such as altered receptor density and sensitivity, in an attempt to maintain homeostasis (Trujillo, 2002). For example, the brain may downregulate GABA receptors and upregulate NMDA receptors, contributing to a state of neuronal hyperexcitability that manifests as a withdrawal syndrome upon drug cessation (Becker, 1998; Trevisan et al., 1998).

A critical mechanism of inhalant-induced brain damage is oxidative stress (Virmani et al., 2010). The metabolism of many solvents generates reactive oxygen species (free radicals) that overwhelm the brain's antioxidant defenses (Toffoletto et al., 2007). These free radicals damage lipids, proteins, and DNA, leading to mitochondrial dysfunction, impaired energy production, and ultimately, apoptosis or necrosis of neurons and glial cells (Virmani et al., 2010; Calingasan et al., 1996). Hypoxic episodes during overdose also trigger oxidative stress and excitotoxicity, where excessive glutamate release leads to massive calcium influx into neurons, activating enzymes that degrade cellular components and lead to cell death (Pujol & Puel, 1999; Aydın et al., 2015). This confluence of direct toxicity, neurotransmitter system dysregulation, oxidative stress, and hypoxia creates a vicious cycle of cellular damage that underlies the progressive and often irreversible neurological sequelae of chronic inhalant abuse (Knox & Nelson, 1966).

### Developmental Neurobiology

The abuse of inhalants is particularly prevalent among adolescents, a fact that raises significant concerns from a developmental neurobiology perspective (Sharp et al., 2008; Takahashi & Franklin, 1996). The adolescent brain is not a fully mature version of the adult brain; it is undergoing a dynamic and protracted period of structural and functional reorganization, rendering it uniquely vulnerable to the neurotoxic and psychoactive effects of drugs (Alfonso‐Loeches & Guerri, 2011; Dubovický, 2010). Exposure to substances like inhalants during this critical developmental window can disrupt normal maturational processes, leading to long-lasting or permanent alterations in brain circuitry and an increased risk for subsequent psychiatric and substance use disorders (Winters & Ingwalson, 2022; McArdle & Angom, 2012).

One of the most important developmental processes occurring during adolescence is the maturation of the prefrontal cortex (PFC) and its connections with limbic and striatal regions (Bramon & Murray, 2001). This process, which includes synaptic pruning and increased myelination, underpins the development of executive functions such as impulse control, decision-making, and risk assessment (Lahey, 2021). The abuse of inhalants and other substances can interfere with this crucial PFC development (Alfonso‐Loeches & Guerri, 2011; Page, 1983). The neurotoxic effects of solvents on white matter are particularly concerning, as they can directly impair the myelination process that is essential for establishing efficient long-range connections (Matsuoka, 2007). This disruption can lead to a state of prolonged PFC immaturity, manifesting as the heightened impulsivity and poor judgment that are characteristic of adolescent substance abusers (Winters & Ingwalson, 2022; Gottlieb & Friedman, 1991).

Adolescence is also a period of heightened sensitivity of the brain's reward system. The mesolimbic dopamine system shows exaggerated responses to rewarding stimuli, including drugs of abuse, during this time (Chambers, 2009). This neurobiological characteristic may make adolescents more susceptible to the reinforcing effects of drugs, facilitating the rapid development of addiction (Winters & Ingwalson, 2022; Daley & Douaihy, 2019). Early onset of substance use, a pattern common with inhalants, is a robust predictor of developing a severe substance use disorder in adulthood (Takahashi & Franklin, 1996; McArdle & Angom, 2012).

Furthermore, the adolescent brain exhibits enhanced neuroplasticity, which, while beneficial for learning, also makes it more susceptible to the long-term changes in gene expression and synaptic strength induced by chronic drug exposure (Kalivas et al., 2003; Alfonso‐Loeches & Guerri, 2011). Drug-induced alterations in neural circuits during this period may become more deeply "wired in," establishing maladaptive patterns of thought and behavior that are difficult to reverse later in life (Stewart, 2003).

The neurodevelopmental hypothesis of schizophrenia posits that the illness results from an interaction between an early developmental vulnerability (genetic or environmental) and later environmental insults, often occurring during adolescence (Bramon & Murray, 2001; McCarty, 2020). Substance abuse, particularly cannabis and stimulants, has been identified as a significant environmental risk factor that can precipitate psychosis in vulnerable individuals (Sommer & Arango, 2017; Mauri, 2016). Given that inhalant abuse can also induce psychotic symptoms and has profound neurotoxic effects, it is plausible that it could act as a similar "second hit," disrupting late-stage brain maturation and increasing the risk of a primary psychotic disorder like schizophrenia in genetically predisposed adolescents (Schaumburg et al., 2007; Yui et al., 2006).

Finally, the cognitive and behavioral consequences of developmental brain impairment can create a vicious cycle. Learning disabilities, attention-deficit/hyperactivity disorder (ADHD), and conduct problems, whether pre-existing or exacerbated by substance use, can lead to academic failure and social difficulties (Nass, 1992; Catheline, 2005). These negative outcomes can, in turn, increase stress and lower self-esteem, further promoting substance use as a maladaptive coping mechanism (Capaldi & Kim, 2014; Page, 2014). This highlights the critical importance of early identification and intervention for substance use in young people to mitigate the potential for cascading negative effects on neurodevelopment and long-term life outcomes (Winters & Ingwalson, 2022).

### Treatment Mechanisms

The management of inhalant intoxication and its associated disorders is multifaceted, addressing acute toxicity, withdrawal phenomena, and long-term dependence. Due to the lack of specific pharmacological antidotes for most inhalants, treatment is largely supportive and symptomatic, drawing on principles established for other poisonings and substance use disorders (Cummings et al., 2013; Sarkar et al., 2023).

#### Management of Acute Intoxication

The immediate priority in acute inhalant intoxication is the stabilization of vital functions, following the standard "ABC" protocol (Airway, Breathing, Circulation) of emergency medicine (Garg & Christian, 2024; Rigaud et al., 2006). Respiratory depression is a major cause of mortality, and patients with compromised airways or inadequate ventilation may require endotracheal intubation and mechanical ventilation (Tiscione & Rohrig, 2021; Wilson & Saukkonen, 2004). Cardiovascular complications, such as arrhythmias and hypotension, are also common and require continuous monitoring and supportive care (Sharp et al., 2008). Hypotension may result from direct cardiotoxicity or vasodilation and is managed with intravenous fluids and, if necessary, vasopressor medications (Belgaumi et al., 2022).

Many patients present with severe agitation, aggression, or psychosis, constituting a psychiatric emergency (Jain et al., 2015; Vilke & Ly, 2022). The biological basis for these symptoms is a state of CNS hyperexcitability and neurotransmitter dysregulation (Keary et al., 2013). The primary goal of pharmacotherapy is to achieve sedation to ensure the safety of the patient and staff, and to reduce physiological stress (Sarkar et al., 2023). Benzodiazepines, such as lorazepam or diazepam, are often the first-line agents due to their GABAergic mechanism, which directly counteracts CNS hyperexcitability (Thompson & Weber, 2021; Lejoyeux & Adès, 1993). In cases of severe psychosis with hallucinations or delusions, antipsychotic medications like haloperidol may be used, often in combination with a benzodiazepine (Sarkar et al., 2023; Neufeld et al., 2019). However, antipsychotics must be used with caution as they can lower the seizure threshold and cause extrapyramidal side effects (Coleman, 2004; Duma & Fung, 2019). Seizures are another serious complication of acute intoxication and are also treated primarily with benzodiazepines, followed by other antiepileptic drugs like phenytoin or phenobarbital if seizures persist (Hantson, 2004; Kramer et al., 1990).

#### Management of Withdrawal

Chronic inhalant use leads to neuroadaptive changes that result in a withdrawal syndrome upon cessation (Sharp et al., 2008). This syndrome is characterized by CNS hyperexcitability and shares many features with alcohol or sedative-hypnotic withdrawal, including anxiety, irritability, tremors, insomnia, nausea, and in severe cases, seizures and delirium (Trevisan et al., 1998; Saitz, 1998; Becker, 1998). The underlying mechanism is a rebound hyperactivity of neurotransmitter systems that were chronically suppressed by the drug, particularly a decrease in GABAergic inhibition and an increase in glutamatergic excitation (Becker & Redmond, 2002).

The management of inhalant withdrawal is modeled on alcohol withdrawal protocols (Yersin, 1999; Thompson & Weber, 2021). Benzodiazepines are the treatment of choice, as they substitute for the GABA-agonist effects of the abused substance, thereby suppressing the symptoms of hyperexcitability and preventing severe complications like seizures and delirium tremens (Aubin et al., 1993; Saitz, 1998). The dose is titrated to control symptoms and then gradually tapered over several days to allow the CNS to readjust to a drug-free state (Yersin, 1999). Supportive care, including hydration, nutritional support (particularly thiamine to prevent Wernicke's encephalopathy), and a quiet environment, is also crucial (Sarkar et al., 2023).

#### Long-Term Treatment and Rehabilitation

Addressing the long-term substance use disorder is essential to prevent relapse (Daley & Douaihy, 2019). Currently, there are no FDA-approved medications specifically for inhalant dependence. Therefore, treatment relies heavily on psychosocial interventions (Saunders et al., 2001). These interventions are based on neurobiological models of addiction that emphasize the roles of craving, conditioned cues, and impaired executive control in maintaining drug-seeking behavior (Hayes & Lingford‐Hughes, 2023; Sanchis‐Segura & Spanagel, 2006).

Cognitive-behavioral therapy (CBT) aims to help patients identify high-risk situations, challenge maladaptive thoughts related to substance use, and develop effective coping strategies to manage cravings and prevent relapse (Daley & Douaihy, 2006). Motivational interviewing is another key approach, designed to resolve ambivalence and enhance the patient's intrinsic motivation to change their behavior (Miller & Rollnick, cited in Dongier, 2003). Network therapy, which involves family members and significant others in the treatment process, can help build a strong social support system to encourage abstinence (Galanter, 2014).

Pharmacotherapy may be used to treat common co-occurring psychiatric disorders such as depression or anxiety (Weaver et al., 2024; Stoller, 2015). Treating these comorbidities is critical, as they can be major drivers of relapse (McIntosh & Ritson, 2001). Selective serotonin reuptake inhibitors (SSRIs) or other antidepressants may be prescribed for depression, while various agents can be used for anxiety (Saeed & Tj, 1998). A comprehensive, integrated treatment plan that addresses both the substance use disorder and any comorbid mental health conditions offers the best prognosis for long-term recovery (Daley & Douaihy, 2006; Keith, 2007).

### Future Directions

The biological and neurological understanding of inhalant intoxication, while growing, remains significantly less developed than that for other major substances of abuse such as alcohol, opioids, or cocaine. Much of the current knowledge is extrapolated from the broader fields of neurotoxicology and addiction science, highlighting a critical need for research specifically focused on the unique properties and consequences of volatile substance abuse (Sharp et al., 2008; Brust, 1999). Several key areas represent important future directions for investigation.

First, there is a pressing need to delineate the specific molecular and receptor-level targets for the diverse array of chemicals abused as inhalants. While broad actions on GABA-A, NMDA, and dopamine systems are hypothesized, the precise binding sites and functional consequences for individual compounds like toluene, butane, or various fluorocarbons are poorly understood (Tiscione & Rohrig, 2021). Unraveling these specific neuropharmacological profiles is a prerequisite for developing targeted pharmacotherapies, which are currently non-existent for inhalant use disorder (Saunders et al., 2001). Future research could employ high-throughput screening and molecular modeling to identify how different solvents interact with ion channels and receptors, potentially revealing novel targets for intervention.

Second, longitudinal neuroimaging studies are essential to characterize the trajectory of brain injury in inhalant abusers. While cross-sectional studies have documented white matter damage and atrophy (Borne et al., 2005; Matsuoka, 2007), prospective studies could track these changes over time in relation to the duration and intensity of use, periods of abstinence, and clinical outcomes. Advanced imaging techniques, such as diffusion tensor imaging (DTI) to assess white matter integrity and functional MRI (fMRI) to probe neural circuit dysfunction, could provide more sensitive biomarkers of brain damage and recovery (Anghelescu et al., 2018). Such studies would be invaluable for understanding the potential for neuroplasticity and recovery, and for evaluating the efficacy of neuroprotective or rehabilitative strategies.

Third, the genetic basis of vulnerability to inhalant abuse and its neurotoxic consequences is a wide-open field for exploration. Genome-wide association studies (GWAS) could identify genetic variants that increase the risk for initiating inhalant use or transitioning to dependence (Winters & Ingwalson, 2022). Furthermore, pharmacogenomic studies could investigate how genetic variations in metabolic enzymes, such as the cytochrome P450 family, influence individual susceptibility to the neurotoxic effects of specific solvents (Gram et al., 1993). Identifying individuals at high genetic risk could inform targeted prevention efforts, especially among vulnerable adolescent populations (Takahashi & Franklin, 1996).

Fourth, a deeper understanding of the cellular mechanisms of neurotoxicity is required. Research into the roles of oxidative stress, mitochondrial dysfunction, neuroinflammation, and apoptosis in solvent-induced brain damage could lead to novel therapeutic approaches (Virmani et al., 2010; Calingasan et al., 1996). Investigating the potential of antioxidants, metabolic enhancers, or anti-inflammatory agents to mitigate brain damage in animal models of chronic inhalant exposure could provide a preclinical basis for future clinical trials (Virmani et al., 2010). This line of research could borrow from advances in understanding neurodegeneration in other contexts, such as hypoxic-ischemic encephalopathy or other toxic exposures (Prajapati et al., 2024; Pendergraft et al., 2014).

Finally, the significant comorbidity between inhalant abuse and other psychiatric disorders, such as depression, anxiety, and psychosis, warrants further investigation (Sharp et al., 2008; Buckley, 2007). It remains unclear whether these disorders are a consequence of neurotoxic brain damage, a result of shared underlying vulnerabilities, or a combination of both (McIntosh & Ritson, 2001). Elucidating these relationships is crucial for developing effective integrated treatment strategies that address both the addiction and the co-occurring mental illness (Daley & Douaihy, 2006). Future research should focus on the temporal relationship between the onset of inhalant use and psychiatric symptoms, and how abstinence and treatment affect the course of both conditions.

### Conclusion

Inhalant intoxication is a multifaceted and perilous substance-induced disorder, characterized by a rapid-onset, transient state of CNS dysfunction that can culminate in severe neurological and psychiatric sequelae (Sharp et al., 2008; Daley & Douaihy, 2019). The biological underpinnings of this condition are rooted in the fundamental properties of volatile organic compounds: their high lipid solubility enables swift passage across the blood-brain barrier, leading to widespread and nonspecific disruption of neuronal membrane integrity and function (Tiscione & Rohrig, 2021; Alfonso‐Loeches & Guerri, 2011). This initial physical interaction precipitates a cascade of neurochemical disturbances, most notably the enhancement of inhibitory GABAergic transmission and antagonism of excitatory NMDA-glutamatergic pathways, which collectively depress CNS activity and produce the characteristic symptoms of intoxication, such as ataxia, disorientation, and altered consciousness (Tseng et al., 2020; Becker & Redmond, 2002). Concurrently, modulation of the mesolimbic dopamine system likely mediates the euphoric and reinforcing effects that drive the development of psychological dependence (Hayes & Lingford‐Hughes, 2023).

The clinical presentation of acute intoxication often manifests as a toxic delirium, an acute confusional state with fluctuating levels of consciousness, cognitive impairment, and perceptual disturbances (Schildkrout, 2014; Lipowski, 1987). In more severe cases, or with specific substances, a frank psychosis with hallucinations and delusions can emerge, reflecting profound dysregulation of dopaminergic and serotonergic circuits (Sharp et al., 2008; Mauri, 2016). Chronic abuse transitions from a functional disorder to a structural one, inflicting lasting and often irreversible damage on the brain. The predilection of solvents for lipid-rich myelin leads to a progressive toxic leukoencephalopathy, characterized by demyelination and diffuse white matter injury (Borne et al., 2005; Prajapati et al., 2024). This structural degradation, coupled with generalized cerebral and cerebellar atrophy from neuronal loss, provides the stark anatomical correlate for the enduring cognitive deficits, memory impairment, and motor coordination problems observed in long-term abusers (Knox & Nelson, 1966; Page, 1983).

The adolescent brain, with its ongoing myelination and synaptic refinement, is exceptionally vulnerable to these neurotoxic insults, and early-life exposure can derail critical neurodevelopmental trajectories, increasing the risk for lifelong psychiatric morbidity and addiction (Dubovický, 2010; Winters & Ingwalson, 2022). While our understanding of these processes has advanced, it is largely built upon inferences from the study of anesthetics, other CNS depressants like alcohol, and specific neurotoxins such as toluene (Winters, 1976; Becker, 1998; Knox & Nelson, 1966). The vast chemical heterogeneity of abused inhalants means that our knowledge remains incomplete, and specific mechanisms for many compounds are yet to be discovered. The lack of targeted pharmacological treatments underscores this knowledge gap. Ultimately, a deeper and more specific neurobiological investigation into the actions of different classes of inhalants is imperative to move beyond supportive care and develop novel, mechanism-based interventions to prevent and treat the devastating neurological consequences of this form of substance abuse.

## References

1. AbdulRahman, I., Yaqoob, Ú., & Bhatti, T. A. (2018). Sleep Disorders Caused by Depression. Clinical Depression. https://doi.org/10.4172/2572-0791.1000131
2. Abe, Y., & Germai, A. (2012). Insomnia and Its Correlates: Current Concepts, Epidemiology, Pathophysiology and Future Remarks. InTech eBooks. https://doi.org/10.5772/36102
3. Abhilash, K. P., Jha, A., Bandhyopadhyay, R., & Victor, P. (2014). Hypoglycemia - A rare complication of carbamazepine overdose. Indian Journal of Pharmacology. https://doi.org/10.4103/0253-7613.144941
4. Abou‐Donia, M. B. (2015). Drugs of Abuse. https://doi.org/10.1002/9781118683484.ch26
5. Adams, B., & Bromley, B. (1998). Loss and grief therapy. https://doi.org/10.1007/978-1-349-26634-0_10
6. Aichmüller, C., & Soyka, M. (2015). Müdigkeit bei Suchterkrankungen. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. https://doi.org/10.4414/smf.2015.02258
7. Al-Balawi, T., Al-Greeshah, F., & Khan, S. (2003). Management of status epilepticus.. PubMed.
8. Al-Tajali, A. N. A. (2015). Low-Dose Clozapine for an Adolescent with TBI-Related Fregoli Delusions. Journal of Psychiatry. https://doi.org/10.4172/2378-5756.1000306
9. Albano, A. M., & Silverman, W. K. (2024). Bipolar Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0016
10. Alfonso‐Loeches, S., & Guerri, C. (2011). Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain. Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.3109/10408363.2011.580567
11. Ali, A. M., Al‐Dossary, S. A., Laranjeira, C., Atout, M., Khatatbeh, H., Selim, A., Alkhamees, A. A., Aljaberi, M. A., Pakai, A., & Al‐Dwaikat, T. (2024). Cardiometabolic Morbidity (Obesity and Hypertension) in PTSD: A Preliminary Investigation of the Validity of Two Structures of the Impact of Event Scale-Revised. Journal of Clinical Medicine. https://doi.org/10.3390/jcm13206045
12. Ali, N., Rasheed, A., Tariq, I., Abdullah, F., Sarwar, A., Atta, R., & Qammer, Z. (2018). Adjunct Use of Low Dose Risperidone Verses Adjunct Use of Clonazepam with an SSRI in Treatment of Moderate to Severe Anxiety States; A Comparative Study. National Journal of Health Sciences. https://doi.org/10.21089/njhs.32.0051
13. Altieri, B., Aini, I., Cannavale, G., Mancini, C., Mancini, C., Zamponi, V., Isidori, A. M., Colao, A., Faggiano, A., Peri, A., Albertelli, M., Alessi, Y., Arecco, A., Arrivi, G., Barrea, L., Benevento, E., Capriotti, G., Ciocca, E., Fata, R. D., ... Vitale, G. (2025). Pathophysiology and treatment of exercise-associated hyponatremia. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-025-02673-7
14. Amihăesei, I. C., & Cojocaru, E. (2014). Main neuroendocrine features, diagnosis and therapeutic possibilities in the chronic fatigue syndrome, an underdiagnosed entity.. PubMed.
15. Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDUCED PSYCHOSIS A CASE REPORT AND BRIEF LITERATURE REVIEW. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b63
16. Anani, S., Goldhaber, G., Wasserstrum, Y., Dagan, A., & Segal, G. (2018). The ‘SILENT Alarm’: When History Taking Reveals a Potentially Fatal Toxicity. European Journal of Case Reports in Internal Medicine. https://doi.org/10.12890/2018_000843
17. Anbar, R. D., & Hall, H. R. (2012). What Is a Functional Respiratory Disorder?. Humana Press eBooks. https://doi.org/10.1007/978-1-61779-857-3_1
18. Anderson, T., Heitger, M., & Macleod, A. D. (2006). Concussion and mild head injury. Practical Neurology. https://doi.org/10.1136/jnnp.2006.106583
19. Andrade, C. (2017). Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.17f11567
20. Andresen, M., & Andresen-Vasquez, M. (2016). A new instrument for assessing the experience of dying and death in the intensive care units from the perspective of relatives. Journal of Thoracic Disease. https://doi.org/10.21037/jtd.2016.06.07
21. Anghel, L., Boev, M., Stănescu, C., Caramfil, S. M., Luca, L., Mușat, C. L., & Ciubară, A. (2023). Depression in the Diabetic Patient. BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE. https://doi.org/10.18662/brain/14.4/526
22. Anghelescu, A., Magdoiu, A. M., Chirilă, I., Verișezan, O., Opincariu, I., Mureșanu, D. F., & Blesneag, A. (2018). None. Romanian Journal of Neurology. https://doi.org/10.37897/rjn.2018.s
23. Anghelescu, A., Magdoiu, A. M., Chirilă, I., Verișezan, O., Opincariu, I., Mureșanu, D. F., & Blesneag, A. (2018). ORAL PRESENTATION – ABSTRACTS. Romanian Journal of Neurology. https://doi.org/10.37897/rjn.2018.s.1
24. Anghelescu, G., Bojescu, A. A., Populeanu, R., Ionică, M., Vlădescu, M., Macovei, R. A., & Caragea, G. (2018). Multiple reactions monitoring for cocaine and ethylbenzoylecgonine to increase the signal/noise ratio in mass spectrometry analysis. Advanced Topics in Optoelectronics, Microelectronics, and Nanotechnologies IX. https://doi.org/10.1117/12.2322569
25. Anisman, H., & Merali, Z. (1999). Understanding stress: characteristics and caveats.. PubMed.
26. Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. (2005). Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies. Current Pharmaceutical Design. https://doi.org/10.2174/1381612053381701
27. Anshel, M. H. (2016). Coping with stress in law enforcement. Routledge eBooks. https://doi.org/10.4324/9781315611075-14
28. Antonio, E., & Alfredo, E. (2012). Cocaine Addiction: Changes in Excitatory and Inhibitory Neurotransmission. InTech eBooks. https://doi.org/10.5772/34410
29. Armstrong, L. E., Casa, D. J., Millard‐Stafford, M., Moran, D. S., Pyne, S. W., & Roberts, W. O. (2007). Exertional Heat Illness during Training and Competition. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/mss.0b013e31802fa199
30. Arnold, L. E. (1993). Clinical Pharmacological Issues in Treating Psychiatric Disorders of Patients with Mental Retardation. Annals of Clinical Psychiatry. https://doi.org/10.3109/10401239309148982
31. Arpacı, A. H., Koç, A., Gürkan, Ö. E., Tosun, C., & Işık, B. (2017). Emergence Agitation or Excited Delirium. Gazi Medical Journal.
32. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2016). Nonconvulsive status epilepticus and psychotic symptoms: case report Stato epilettico non convulsivo e sintomi psicotici: caso clinico.
33. Aurangabadkar, K. (2024). Movement Disorders in Neurocritical Care. https://doi.org/10.1007/978-981-99-8059-8_55
34. Avari, J., Yuen, G. S., AbdelMalak, B., Mahgoub, N., Kalayam, B., & Alexopoulos, G. S. (2014). Assessment and Management of Late-Life Depression. Psychiatric Annals. https://doi.org/10.3928/00485713-20140306-04
35. Aveyard, P., & Raw, M. (2012). Improving smoking cessation approaches at the individual level. Tobacco Control. https://doi.org/10.1136/tobaccocontrol-2011-050348
36. Ay, D. (2010). A Case of Transient Global Amnesia due to Marijuana Use. Journal of Academic Emergency Medicine. https://doi.org/10.4170/jaem.2010.40085
37. Ayala, L., Gómez‐Revuelta, M., Requena, C. M., Acilu, E. S. D. A. G. D., Olivares, O. P., Ruíz, M. J., Morales, N. N., Martin, M., Zufiaurre, M. L., Hernández, B., Itoiz, A. A., Peña, M., & González‐Pinto, A. (2017). Clozapine: Since the very beginning?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.1402
38. Aydın, M., Deveci, U., & Orman, A. (2015). Neurotoxic Treatments in the Newborn Period. International Journal of Neurology Research. https://doi.org/10.17554/j.issn.2313-5611.2015.01.23
39. Ayşe, H., Hakkı, ©., Arpacı, A. H., Koç, A., Gürkan, Ö. E., Tosun, C., & Işık, B. (2017). Emergence Agitation or Excited Delirium?. Gazi Medical Journal. https://doi.org/10.12996/gmj.2017.45
40. Bach, J. (2015). Unintentional Harm of Older Adults.
41. Backer, W. D. (2006). Obstructive Sleep Apnea-Hypopnea Syndrome. KARGER eBooks. https://doi.org/10.1159/000093150
42. Bagdy, G., Riba, P., Kecskeméti, V., Chase, D., & Juhász, G. (2010). Headache‐type adverse effects of NO donors: vasodilation and beyond. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.00643.x
43. Baldwin, D. S., Ajel, K., & Garner, M. (2008). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.002
44. Bansal, R., & Sheldon, S. H. (2008). Parasomnias in Childhood. CRC Press eBooks. https://doi.org/10.3109/9781420048087-26
45. Barnovitz, M. A. L. C. M., & Joglekar, P. M. (2007). Medical Psychiatry: The Quick Reference.
46. Baronia, R. B. (2015). Oral Hydrocodone Induced Acute Psychosis in an Adult Male: A CaseReport.. Journal of Clinical Case Reports. https://doi.org/10.4172/2165-7920.1000535
47. Barreno, E. M., López, M. J. R., & Menéndez, M. J. C. (2003). Trastornos cognitivos y psicóticos en un caso de epilepsia temporal antes y después de la lobectomía.
48. Barrio, A. G. D. (2018). Intervención Psicoterapéutica Integrada y Transdiagnóstica en los Trastornos de la Conducta Alimentaria. Revista de Psicoterapia. https://doi.org/10.33898/rdp.v29i110.248
49. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
50. Batta, A., & Farid, B. (2011). Addiction in Adolescents ---- A Current Trend.
51. Becker, H. C. (1998). Kindling in alcohol withdrawal.. PubMed.
52. Becker, H. C., & Redmond, N. (2002). Role of Glutamate in Alcohol Withdrawal Kindling. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-306-4_25
53. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
54. Belgaumi, N., Salik, A., & Siddiqui, N. U. R. (2022). Shock Pathophysiology: Classifications and Management. IntechOpen eBooks. https://doi.org/10.5772/intechopen.105506
55. Benedek, D. M., & Wynn, G. H. (2016). Posttraumatic Stress Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190205959.003.0002
56. Berg, A. T. (2011). Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02905.x
57. Bermúdez, C. M., & Barrientos, M. P. S. (2011). Manejo Integral de un paciente con secuelas neuropsiquiátricas por consumo crónico de alcohol. REVISTA MÉDICAS UIS.
58. Bernard, S., Enayati, A., Binstock, T., Roger, H., Redwood, L., & McGinnis, W. (2004). Autism: A Unique Type of Mercury Poisoning.
59. Bhat, P., Ryali, V., Srivastava, K., Kumar, S., Prakash, J., & Singal, A. (2012). Alcoholic hallucinosis. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.119646
60. Bidaki, R., Rahavi, A., Dehghani, F., Ghanei, M. E., Zaer-Alhosseini, N., & Khorasani, M. (2020). Delayed Neurological Sequelae Following Carbon Monoxide Poisoning and Skin Graft: A Case Report. Hospital Practices and Research. https://doi.org/10.34172/hpr.2020.30
61. Bie, R. M. A. D., & Holter, S. E. M. T. (2016). Advanced Treatment for Dystonia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190607555.003.0019
62. Billiard, M., & Carlander, B. (2003). Other hypersomnias. SLEEP. https://doi.org/10.1007/978-1-4615-0217-3_34
63. Binder, L. M., Spector, J. J., & Youngjohn, J. R. (2012). Psychogenic Stuttering and Other Acquired Nonorganic Speech and Language Abnormalities. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acs051
64. Birkenhäger-Gillesse, E. G., & Poel, M. F. P. V. D. (2008). [Carbon monoxide poisoning; psychotic depression brought on by a new kitchen].. Tijdschrift voor psychiatrie.
65. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
66. Blackburn, L. B., Zelko, F., & Shurtleff, H. A. (2001). Seizure disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545894.008
67. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
68. Bogaczewicz, J., Sobów, T., Bogaczewicz, A., Robak, E., Bieńkowski, P., Sysa‐Jędrzejowska, A., & Woźniacka, A. (2013). Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus—a case report. Lupus. https://doi.org/10.1177/0961203313513818
69. Boggs, C. L., Ripple, M., Ali, Z., Brassell, M., Levine, B., Jufer‐Phipps, R., Doyon, S., & Fowler, D. R. (2013). Anaphylaxis After the Injection of Buprenorphine. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.12161
70. Bolton, E., Holohan, D. R., King, L. A., & King, D. W. (2004). Acute and Post-Traumatic Stress Disorder. Routledge eBooks. https://doi.org/10.4324/9780203336960-13
71. Bonnet, M. H., & Arand, D. L. (2008). Chronic insomnia. CRC Press eBooks. https://doi.org/10.3109/9780203091715-12
72. Borchers, A., & Cagle, L. A. (2018). Look‐Alike Causes of Respiratory Distress. https://doi.org/10.1002/9781119028994.ch50
73. Borie, Y. A., Tamiso, A., Gutema, K., Jisso, M., Deribe, B., Fikre, R., Defar, S., Ayalew, M., & Abera, W. (2024). Psychological distress and its associated factors among people with specific chronic conditions (diabetes and/or hypertension) in the Sidama region of southern Ethiopia: A cross-sectional study. PLoS ONE. https://doi.org/10.1371/journal.pone.0303196
74. Borne, J., Riascos, R., Cuellar, H., Vargas, D., & Rojas, R. (2005). Neuroimaging in Drug and Substance Abuse Part II. Topics in Magnetic Resonance Imaging. https://doi.org/10.1097/01.rmr.0000192154.34563.6b
75. Bostankolu, G., Ayhan, Y., Çetin, F. Ç., & Yazıcı, M. K. (2014). Serotonin syndrome with a combination of aripiprazole and fluoxetine: a case report. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125314561467
76. Bostwick, J. R., & Demehri, A. (2017). Pills to Powder: An Updated Clinician's Reference for Crushable Psychotropics. Current psychiatry.
77. Bouritius, E. M., Neven, A. K., & Blom, J. D. (2015). [Alcohol hallucinosis].. PubMed.
78. Bousoño, M., Baca, E., Alvarez, E., Eguiluz, I., Martin, M., Roca, M., & Urretavizcaya, M. (2008). Complicaciones de la depresión a largo plazo. Actas Españolas de Psiquiatría.
79. Braksick, S. A., & Wijdicks, E. F. M. (2019). Neurogenic Cardiac Manifestations. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190862923.003.0017
80. Bramon, E., & Murray, R. (2001). A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2001.3.4/ebramon
81. Breuer, L., Kasper, B. S., Schwarze, B., Gschossmann, J. M., Kornhuber, J., & Müller, H. (2015). “Herbal seizures” – atypical symptoms after ibogaine intoxication: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/s13256-015-0731-4
82. Brignole, M., Alboni, P., Benditt, D. G., Bergfeldt, L., Blanc, J., Thomsen, P. E. B., Dijk, J. G. V., Fitzpatrick, A., Hohnloser, S. H., Janousek, J., Kapoor, W. N., Kenny, R. A., Kułakowski, P., Masotti, G., Moyá, A., Raviele, A., Sutton, R., Theodorakis, G., Ungar, A., & Wieling, W. (2004). Guidelines on Management (diagnosis and treatment) of syncope ? update 2004. EP Europace. https://doi.org/10.1016/j.eupc.2004.08.008
83. Brodrick, J. E., & Mitchell, B. G. (2015). Hallucinogen Persisting Perception Disorder and Risk of Suicide. Journal of Pharmacy Practice. https://doi.org/10.1177/0897190014566314
84. Brody, D. L. (2019). Anxiety and Depression. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0011
85. Brody, D. L. (2019). How Do You Make the Diagnosis of Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0003
86. Brody, D. L. (2019). Mood Instability and Irritability. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0010
87. Bromberger, J. T. (1998). Gender and Depression. https://doi.org/10.1093/oso/9780195113969.003.0003
88. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
89. Brust, J. C. (1999). Substance Abuse, Neurobiology, and Ideology. Archives of Neurology. https://doi.org/10.1001/archneur.56.12.1528
90. Brust, J. C. (2002). Neurologic Complications of Substance Abuse. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/00126334-200210012-00002
91. Brust, J. C. (2002). Seizures and Illicit Drug Use. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-094-0_11
92. Brüne, M. (2008). Dementia. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199207688.003.0009
93. Buckley, P. (2007). Dual Diagnosis of Substance Abuse and Severe Mental Illness: The Scope of the Problem. Journal of Dual Diagnosis. https://doi.org/10.1300/j374v03n02_07
94. Buckley, P., & Foster, A. (2014). Schizophrenia. https://doi.org/10.1007/978-3-7091-0715-7_4
95. Burchardi, H. (2004). Aims of sedation/analgesia.. PubMed.
96. Burk, A., Merchant, A., Rahman, H., Patel, A., Deshmukh, I., Merchant, R., Yam, A. A., Yu, A., Cai, C., Hassam, A., Le, D., & Lambroussis, C. G. (2025). Serotonin Syndrome Without Overdose: Polypharmacy-Induced Toxicity in a Medically Stable Young Adult. Cureus. https://doi.org/10.7759/cureus.86587
97. Burkhart, P. W. M. K. K. (2014). Drugs Highly Associated with Infusion Reactions Reported using Two Different Data-mining Methodologies. Journal of Blood Disorders & Transfusion. https://doi.org/10.4172/2155-9864.1000195
98. Bustos, W. P. V., & Vásquez, A. P. G. (2018). Intoxicación oral por benzodiacepinas. Reporte de caso y revisión bibliográfica.
99. Bálint, G. S. (2003). [Premeditated ecstasy?].. PubMed.
100. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Post-Stroke Apathy: An Exploratory Longitudinal Study. Cerebrovascular Diseases. https://doi.org/10.1159/000350202
101. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Supplementary Material for: Post-Stroke Apathy: An Exploratory Longitudinal Study. Figshare. https://doi.org/10.6084/m9.figshare.5124829
102. Calingasan, N. Y., Sheu, K. R., Baker, H., Gandy, S., & Gibson, G. E. (1996). Thiamine Deficiency as a Model of Selective Neurodegeneration with Chronic Oxidative Deficits. Neurodegenerative Diseases. https://doi.org/10.1007/978-1-4899-0209-2_25
103. Callahan, C. M., Austrom, M. G., & Unverzagt, F. W. (2004). Dementia and Late-Life Depression. https://doi.org/10.1093/oso/9780195149395.003.0021
104. Calvani, M., Anania, C., Cuomo, B., D’Auria, E., Decimo, F., Indirli, G. C., Mastrorilli, V., Santoro, A., Sartorio, M. U. A., & Veronelli, E. (2020). Summation anaphylaxis: A challenging diagnosis. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.13347
105. Capaldi, D. M., & Kim, H. K. (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
106. Catalani, S., & Apostoli, P. (2011). [Neurotoxic effects of cobalt: an open question].. PubMed.
107. Catheline, N. (2005). [Academic problems and school failure in adolescence].. PubMed.
108. Ceravolo, F., Sestito, S., Falvo, F., Salpietro, V., Polizzi, A., Ruggieri, M., Bruno, M., & Concolino, D. (2016). Neurological Involvement in Inherited Metabolic Diseases: An Overview. Journal of Pediatric Biochemistry. https://doi.org/10.1055/s-0036-1582235
109. Chambers, R. A. (2009). A Nicotine Challenge to the Self-Medication Hypothesis in a Neurodevelopmental Animal Model of Schizophrenia. Journal of Dual Diagnosis. https://doi.org/10.1080/15504260902869808
110. Chang, Y., Han, I.-W., Na, H. R., & Kim, S.-Y. (2010). Encephalitis Lethargica With Catatonia. Journal of the Korean Neurological Association.
111. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
112. Charlton, S. R. (2020). Psychology and Black History Month in the United States. Eye on Psi Chi Magazine. https://doi.org/10.24839/2164-9812.eye24.4.18
113. Chatterton, C., & Jones, G. (2013). Interpretative aspects of toxicological results. https://doi.org/10.4155/ebo.13.54
114. Chaudhry, H., Arshad, N., Niaz, S., Cheema, F., Iqbal, M., & Mufti, K. (2005). Fifteen-year follow-up of conversion disorder. International Psychiatry. https://doi.org/10.1192/s1749367600007517
115. Chaudhry, S. (2020). Depression and its Dilemma. IP Journal of Surgery and Allied Sciences. https://doi.org/10.18231/j.jsas.2020.013
116. Chauhan, R., Bhunal, S., Gupta, D., Kumar, R., & Sharma, T. (2020). TO STUDY CLINICAL PROFILE OF ACUTE CONFUSIONAL STATE IN A TERTIARY CARE HOSPITAL IN A HILLY AREA.. International Journal of Scientific Research. https://doi.org/10.36106/ijsr/0915904
117. Cheema, C. S. S. C. C. S. S. (2013). Meditation for stress reduction in Indian Army- An Experimental Study. IOSR Journal of Business and Management. https://doi.org/10.9790/487x-1022737
118. Chitsaz, A. (2017). Stroke And Substance Abuse. Advances in Bioscience and Clinical Medicine. https://doi.org/10.7575/aiac.abcmed.ca1.34
119. Choi, S. J. (2007). Sleep Breathing Disorder. Tuberculosis & respiratory diseases. https://doi.org/10.4046/trd.2007.63.1.5
120. Chouinard, G., & Chouinard, V. (2015). New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000371865
121. Chummun, H., Tilley, V., & Ibe, J. (2010). 3,4-methylenedioxyamfetamine (ecstasy) use reduces cognition.. British Journal of Nursing.
122. Cianchetti, C., Pruna, D., & Ledda, M. (2013). Epileptic seizures and headache/migraine: A review of types of association and terminology. Seizure. https://doi.org/10.1016/j.seizure.2013.05.017
123. Cid, M. L. F. (2008). Síndrome de neurotoxicidad inducido por opioides (NIO). Revista de la Sociedad Española del Dolor.
124. Ciraulo, D. M., & Ciraulo, D. A. (2008). Benzodiazepines <i>Misuse, Abuse, and Dependence</i>. https://doi.org/10.1093/oso/9780195300550.003.0019
125. Ciszowski, K., & Mietka-Ciszowska, A. (2013). [Rare consciousness disturbances in toxicological practice: akinetic mutism, somnambulism, locked-in syndrome, and psychogenic coma].. PubMed.
126. Ciszowski, K., & Mietka-Ciszowska, A. (2013). [Toxicant-induced and drug-induced coma neurotoxicological issues of general anesthesia].. PubMed.
127. Clay, S., Allen, J. V., & Parran, T. (2008). A Review of Addiction. Postgraduate Medicine. https://doi.org/10.3810/pgm.2008.07.1802
128. Cohen, J. A., Mowchun, J. J., Lawson, V. H., & Robbins, N. M. (2016). A 19-Year-Old Male with Stiffness and Weakness After Waking. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190491901.003.0026
129. Coleman, J. J. (2004). Drug-induced seizures. Adverse Drug Reaction Bulletin. https://doi.org/10.1097/00012995-200408000-00001
130. Colán, T. C., Gálvez, G. A., & Zevallos, D. C. (2013). Síntomas psiquiátricos e insulinoma: reporte de caso Psychiatric symptoms and insulinoma: a case report.
131. Connell, J., Oldham, M., Pandharipande, P. P., Dittus, R. S., Wilson, A. M., Mart, M. F., Heckers, S., Ely, E. W., & Wilson, J. E. (2022). Malignant Catatonia: A Review for the Intensivist. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666221114303
132. Cooper, L., Copeland, S., Dailey, S., Downey, D., Petersen, M. C., Stimson, C., & Dyke, D. C. V. (2008). Feeding and swallowing dysfunction in genetic syndromes. Developmental Disabilities Research Reviews. https://doi.org/10.1002/ddrr.19
133. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
134. Correia‐Melo, F. S., Silva, S. S., Araújo-de-Freitas, L., & Quarantini, L. C. (2017). S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression. Brazilian Journal of Psychiatry. https://doi.org/10.1590/1516-4446-2016-2070
135. Costanzo, R. M., DiNardo, L. J., Reiter, E. R., & Doty, R. L. (2003). Head Injury and Taste. CRC Press eBooks. https://doi.org/10.1201/9780203911457-50
136. Costentin, J. (2015). La dopamine dans tous ses états.
137. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
138. Crino, P. B. (2002). Seizures in Acute Neurological Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-094-0_3
139. Crippa, M., Toffoletto, F., & Torri, D. (2007). [Interactions between alcohol and work exposure to chemical substances].. La Medicina del lavoro.
140. Cruz, M. C. D., Camargo, R. P. D., Cruz, L. C. D., Schiefelbein, N., Cruz, D. M. D., & Cruz, M. C. C. D. (2020). Migrânea: revisão de literatura. ARCHIVES OF HEALTH INVESTIGATION. https://doi.org/10.21270/archi.v10i2.4670
141. Cruz, S. L., & López, C. B. (2003). Fármacos que producen dependencia física y adicción. Avance y perspectiva.
142. Cuevas, M. J. S. (2005). EL TRASTORNO POR DÉFICIT DE ATENCIÓN CON HIPERACTIVIDAD (314.01) Y SU INCIDENCIA EN EL MEDIO ESCOLAR, FAMILIAR Y SOCIAL EN EL CAMPO DE GIBRALTAR. Almoraima:  revista de estudios campogibraltareños.
143. Cummings, P. M., Trelka, D. P., & Springer, K. M. (2013). Poisoning. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511920905.007
144. Cunningham, S. (2019). Communicating Auditory Impairments Using Electroacoustic Composition. Electronic workshops in computing. https://doi.org/10.14236/ewic/eva2019.63
145. Cüreoǧlu, S., FUKUSHIMA, H., Schachern, P. A., Paparella, M. M., & HARADA, T. (2005). The Effects of Type 2 Diabetes Mellitus on the Cochlear Structure in Human Temporal Bones. Otolaryngology. https://doi.org/10.1016/j.otohns.2005.05.545
146. Daley, D. C., & Douaihy, A. (2006). Medications in Dual Recovery. https://doi.org/10.1093/oso/9780195311297.003.0006
147. Daley, D. C., & Douaihy, A. (2006). The Recovery Process for Addiction and Mood Disorders. https://doi.org/10.1093/oso/9780195311297.003.0004
148. Daley, D. C., & Douaihy, A. (2006). Understanding Mood Disorders: Depression and Bipolar Illness. https://doi.org/10.1093/oso/9780195311297.003.0003
149. Daley, D. C., & Douaihy, A. (2019). Psychiatric Illness Co-occurring with a Substance Use Problem. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0008
150. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
151. Dalvi, A., Lyons, K. E., & Pahwa, R. (2006). Secondary Dystonia. CRC Press eBooks. https://doi.org/10.3109/9781420019988-19
152. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
153. Darriba, H. B. (2023). A complex polymorphous psychosis or a cycloid psychosis with a different onset?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2246
154. Das, S., & Shil, R. (2024). Psychedelic Drugs: A Mind-expanding Hallucinogens. Indian Journal of Behavioural Sciences. https://doi.org/10.55229/ijbs.v27i1.13
155. Deakin, J., & Lennox, B. (2013). Psychotic symptoms in young people warrant urgent referral.. PubMed.
156. Delgado, D. A. O., Rojas, M. C. O., & Olea, J. M. S. (2024). Episodio depresivo mayor de características catatónicas: Reporte de caso. Revista Científica de Salud y Desarrollo Humano. https://doi.org/10.61368/r.s.d.h.v5i1.75
157. Dengler, R., Kolbe, H., & Müller‐Vahl, K. (1999). Transient severe parkinsonism after acute organophosphate poisoning. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.66.2.253
158. Dennis, M., Warlow, C. P., Gijn, J. V., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P., Rinkel, G. J., Langhorne, P., Sudlow, C., & Rothwell, P. M. (2008). What are This Patient's Problems?: A Problem‐Based Approach to the General Management of Stroke. Stroke. https://doi.org/10.1002/9780470696361.ch11
159. Dhar, N., Shree, R., Radhakrishnan, D. M., & Kumar, N. (2020). Hearing Loss in Migraine: An Uncommon Manifestation of a Common Disorder. Journal of Neurosciences in Rural Practice. https://doi.org/10.1055/s-0040-1713337
160. Dhingra, L., Ahmed, E., Shin, J. G., Scharaga, E., & Magun, M. (2015). Cognitive Effects and Sedation. Pain Medicine. https://doi.org/10.1111/pme.12912
161. Dias, E., GP, V., & Kavya, K. (2022). Evaluation of a 16 Days Neonate with SIDS: A Case of Massive Breast Milk Aspiration. Acta Scientific Paediatrics. https://doi.org/10.31080/aspe.2022.05.550
162. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
163. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
164. Dodge, N. C., Jacobson, J. L., Lundahl, L. H., & Jacobson, S. W. (2023). Prenatal alcohol exposure and attention‐deficit/hyperactivity disorder independently predict greater substance use in young adulthood. Alcohol Clinical and Experimental Research. https://doi.org/10.1111/acer.15076
165. Dolenc, T. J. (2015). Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214883.003.0044
166. Donghi, A., Maidana, M., Vázquez, L. G., & Rodríguez, R. O. (2011). DIAGNÓSTICO DIFERENCIAL (NEUROSIS-PSICOSIS) DEL MODO DE TRATAMIENTO DEL DOLOR EN CONSUMIDORES DE PASTA BASE DE COCAÍNA (PACO). III Congreso Internacional de Investigación y Práctica Profesional en Psicología XVIII Jornadas de Investigación Séptimo Encuentro de Investigadores en Psicología del MERCOSUR.
167. Dongier, M. (2003). What treatment options exist for alcohol abuse?. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn.0307
168. Dore, G., & Sweeting, M. (2006). Drug-Induced Psychosis Associated with Crystalline Methamphetamine. Australasian Psychiatry. https://doi.org/10.1080/j.1440-1665.2006.02252.x
169. Dore, G., & Sweeting, M. (2006). Drug-induced psychosis associated with crystalline methamphetamine. Australasian Psychiatry. https://doi.org/10.1111/j.1440-1665.2006.02252.x
170. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
171. Doğan, K. H., Özbek, S., Doğan, N. Ü., & Karabulut, A. K. (2014). Karbonmonoksit İntoksikasyonu Sonrası Gelişen Geç Nörolojik Sendrom Olgu Sunumu. Deleted Journal. https://doi.org/10.17986/blm.2014191768
172. Dr.V, S. (2020). INNOVATIVE RESEARCH ABOUT SCHOOL TEACHERS STRESS AND SUSTAINABLE STRATEGIES TO ELIMINATE SCHOOL TEACHERS STRESS. International Journal of Psychosocial Rehabilitation. https://doi.org/10.37200/ijpr/v24i4/pr201100
173. Drago, F., & Caraci, F. (2020). Faculty Opinions recommendation of Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review.. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. https://doi.org/10.3410/f.733303213.793576054
174. Dubovický, M. (2010). Neurobehavioral manifestations of developmental impairment of the brain. Interdisciplinary Toxicology. https://doi.org/10.2478/v10102-010-0012-4
175. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
176. Duma, S., & Fung, V. S. (2019). Drug-induced movement disorders. Australian Prescriber. https://doi.org/10.18773/austprescr.2019.014
177. Dunea, G. (2004). Soundings: Three puzzling cases. BMJ.
178. Ebenezer, I. S. (2015). Drug Abuse and Addiction. https://doi.org/10.1002/9781118385777.ch11
179. Efe, A., Cura, M., Öztürk, Y., Kaşak, M., Seçer, S., & Yükse, D. (2024). A Rare Phenomenon, Recurrent Acute Dystonia after Withdrawal of ‘Methylphenidate-immediate Release Form’: A Pediatric Case with ADHD. Clinical Psychopharmacology and Neuroscience. https://doi.org/10.9758/cpn.24.1158
180. Efeoğlu, P., Dağlıoğlu, N., Hilal, A., & Gülmen, M. K. (2013). Drugs Used in Sexual Assaults: Features and Toxicological Investigations. DergiPark (Istanbul University).
181. Elliot, G. T. (1991). TWO CASES OF DERMATITIS HERPETIFORMIS DEVELOPING AFTER SEVERE MENTAL EMOTION AND SHOCK. Archives of Dermatology. https://doi.org/10.1001/archderm.1991.01680080062003
182. Eskander, F. S. L., Hakim, K. Y. K., Ibrahim, D., & ElMallah, W. (2021). Incidence Of Post-Operative Delirium In Geriatric Patients Undergoing Hip Replacement Surgery Using Pre-Operative Haloperidol. QJM. https://doi.org/10.1093/qjmed/hcab086.109
183. Espiridion, E. D., Mitchell, C., & Kadakia, S. (2020). Pseudobulbar Affect Presenting as Hypomania. Cureus. https://doi.org/10.7759/cureus.7308
184. Esquiliano, G. R., Ramírez, I. M., Valdés, A. T., & Aguilar, C. A. T. (2004). Daño neurológico secundario a hipoxia isquemia perinatal. Archivos de neurociencias (México, D.F.).
185. et.al., J. F. L. (2002). Neurobiology of tic disorders, including Tourette’s syndrome. https://doi.org/10.1093/oso/9780195141733.003.0013
186. Falk, A., Joseph, R., Smith, S., & Wilk, A. (2023). Mood and Anxiety Disorders: Major Depressive Disorder.. PubMed.
187. Faravelli, C., Zucchi, T., Perone, A., Salmoria, R., & Viviani, B. (2001). Social Phobia. https://doi.org/10.1002/0470846437.ch7
188. Farne, H., Norris-Cervetto, E., & Warbrick‐Smith, J. (2015). Blackout. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198716228.003.0009
189. Fava, G. A., Benasi, G., & Cosci, F. (2017). The Potential Role of Iatrogenic Comorbidity in the Interaction between Pharmacotherapy and Psychotherapy in Anxiety Disorders. Verhaltenstherapie. https://doi.org/10.1159/000460826
190. Favrat, B., Guessous, I., Gonthier, A., & Cornuz, J. (2015). [Prolonged or chronic fatigue of unknown origin].. PubMed.
191. Favrat, B., Guessous, I., Gonthier, A., & Cornuz, J. (2015). Anhaltende bzw. chronische Müdigkeit unbekannter Ätiologie. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. https://doi.org/10.4414/smf.2015.02260
192. Fazel, M., Reed, R. V., & Goldring, L. (2012). Post-traumatic stress disorder. BMJ. https://doi.org/10.1136/bmj.e3790
193. Filho, A. C. O., Gomes, L. M. T., Corrêa, A. C., Leão, E. F. D., Cangussu, D. M., & Torres, S. D. A. S. (2019). BRUXISMO DO SONO. Revista Intercâmbio.
194. Fine, L., Dubrovsky, B., & Spielman, A. J. (2011). Insomnia. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805153311101010137
195. Fingerhood, M. (2020). Sedatives. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197506172.003.0005
196. Finsterer, J., & Frank, M. (2015). Takotsubo Syndrome in Metabolic Myopathy Unmasked by Statin-triggered Rhabdomyolysis. Internal Medicine. https://doi.org/10.2169/internalmedicine.54.5376
197. Fischer, T., Agar, M., Hosie, A., & Teodorczuk, A. (2020). Unpacking agitation in practice: a call for greater precision. Age and Ageing. https://doi.org/10.1093/ageing/afaa110
198. Fontalba-Navas, A., & Caparros-del-Moral, I. (2015). New Approaches to Psychotic Agitation: Staccato Loxapine. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30809-9
199. Foo, Y.-C., Tam, C. L., Ehsan, S. D., & Cheah, J. (2012). Impacts of Drug Use on Memory. AUSTRALIAN JOURNAL OF BASIC AND APPLIED SCIENCES.
200. Fountoulakis, K. Ν., Andreoulakis, E., & Iacovides, A. (2013). Nonsensory Hallucinations or Obsessive Symptoms?. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/nmd.0b013e3182a21864
201. Fouwels, A., & Timmer, T. J. (2007). [Choking caused by antipsychotics].. PubMed.
202. Francis, M. V. (2016). Migraine without Aura -Towards a New Definition. Journal of Headache & Pain Management. https://doi.org/10.4172/2472-1913.100008
203. Franjić, S. (2023). Post-Traumatic Stress Disorder Appears as a Traumatic Experience. https://doi.org/10.61440/jcpn.2023.v1.04
204. Fregonese, L., Silvestri, M., Sabatini, F., Defilippi, A., & Rossi, G. A. (2001). Severe and near-fatal asthma in children and adolescents.. PubMed.
205. Fuller, D. D., Mitchell, G. S., & Bavis, R. W. (2005). Respiratory Neuroplasticity: Respiratory Gases, Development, and Spinal Injury. CRC Press eBooks. https://doi.org/10.3109/9780203027103-13
206. Gagliardi, B., Luscher, V., Monin, Y., Kherad, O., & Coronado, L. (2021). [Sleep disturbances related to nocturnal nuisances in elderly inpatients].. PubMed.
207. Gajbhiye, S., Agrawal, R., Atal, S., Tiwari, V., & Phadnis, P. (2015). Exercise-induced anaphylaxis and antileukotriene montelukast. Journal of Pharmacology and Pharmacotherapeutics. https://doi.org/10.4103/0976-500x.162007
208. Galanter, M. (2014). Network Therapy for Substance Use Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg60
209. Galasko, D. (2019). Pharmacological Approaches To Behavioral Symptoms In Alzheimer’s Disease. CRC Press eBooks. https://doi.org/10.1201/9780429260353-28
210. Garg, T., & Rawat, V. S. (2023). Trihexyphenidyl Use Disorder and Withdrawal Syndrome. Journal of Psychiatry Spectrum. https://doi.org/10.4103/jopsys.jopsys_12_23
211. Garg, U., & Christian, M. (2024). 5 Emergency and Intensive Care Management. CRC Press eBooks. https://doi.org/10.1201/9781003449713-5
212. Gaskill, H. S. (1945). MARIHUANA, AN INTOXICANT. American Journal of Psychiatry. https://doi.org/10.1176/ajp.102.2.202
213. Gaudiano, B. A. (2012). The Need to Develop Innovative Interventions to Improve Treatment Adherence in Co-Occurring Severe Mental Illness and Substance Use Disorders. Journal of Addiction Research & Therapy. https://doi.org/10.4172/2155-6105.s8-e001
214. Gehricke, J., Loughlin, S. E., Whalen, C. K., Potkin, S. G., Fallon, J., Jamner, L. D., Belluzzi, J. D., & Leslie, F. M. (2007). Smoking to self-medicate attentional and emotional dysfunctions. Nicotine & Tobacco Research. https://doi.org/10.1080/14622200701685039
215. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
216. Gerner, P., Srinivasa, V., & Eappen, S. (2003). Mutism as a Complication of Total Intravenous Anesthesia by Propofol. Anesthesia & Analgesia. https://doi.org/10.1213/01.ane.0000068119.81418.28
217. Giannopoulos, I., Jupe, T., & Provi, K. (2024). Sleep architecture disturbance due to the use of benzodiazepines. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1614
218. Glasper, E. A., McEwing, G., & Richardson, J. M. (2011). Chapter 13 Mental health problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199547197.003.0075
219. Glueck, B. (2017). Psychophysiological Correlates of Meditation: Eeg Changes During Meditation *. Routledge eBooks. https://doi.org/10.4324/9780203785843-56
220. Goldberg, J. F., Singer, T. M., & Garno, J. L. (2001). Suicidality and substance abuse in affective disorders.. PubMed.
221. Golden, C. J., & Golden, Z. L. (2004). Traumatic Brain Injury. Routledge eBooks. https://doi.org/10.4324/9780203336960-19
222. Goldfeder, S., Scott, R., & Briggs, J. P. (2023). Forensic Assessments of Alcohol, Cannabis and Methamphetamine Intoxication in Cases of Violent Offending.. PubMed.
223. Goldstein, T. R. (2010). Bipolar Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0134
224. González, R. M., Quesada, H. S., & Sancho, L. V. (2010). Episodio mixto secundario al uso de fluoxetina en una paciente con un transtorno afectivo bipolar no diagnosticado. Revista Médica de Costa Rica y Centroamérica.
225. Good, M. I. (1989). Substance-Induced Dissociative Disorders and Psychiatric Nosology. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-198904000-00003
226. Gordon, M. F., & Leder, A. (2012). Serotonin Syndrome. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-835-5_18
227. Gore, H., & Wood, S. (2006). feeding and swallowing difficulties. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198567240.003.0006
228. Gottlieb, S., & Friedman, S. B. (1991). Conduct Disorders in Children and Adolescents. Pediatrics in Review. https://doi.org/10.1542/pir.12.7.218
229. Graddy, R., & Rastegar, D. A. (2025). Stimulants. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197796207.003.0008
230. Grajales, D. V. (2019). La posesión demoníaca: psicosis, neurosis histérica o trastorno neuropsicológico. Poiésis. https://doi.org/10.21501/16920945.3198
231. Gram, L. F., Brøsen, K., Sindrup, S. H., & Skjelbo, E. (1993). Risk factors in elderly taking psychotropic drugs: Significance of genetic polymorphism in drug oxidation. Nordic Journal of Psychiatry. https://doi.org/10.3109/08039489309102787
232. Grant, I., Sacktor, N., & McArthur, J. C. (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
233. Greulich, N., & Klepper, J. (2019). Sudden Uncontrolled Laughter - Behavioral Disorder or Serious Neurological Symptom?. Neuropediatrics. https://doi.org/10.1055/s-0039-1698160
234. Griffiths, M. D., Hodgson, R. J., & Budd, R. (2001). Compulsive Behaviours. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_131
235. Griswold, K., Regno, P. A. D., & Berger, R. C. (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care.. PubMed.
236. Guandique, R. Y., & Vásquez, C. Y. P. (2009). Factores de riesgo que provocan estrés laboral en los docentes universitarios.
237. Guey, J., Charles, C., Coquery, C. M., Roger, J., & Soulayrol, R. (1967). Study of Psychological Effects of Ethosuximide (Zarontin) on 25 Children suffering from Petit Mai Epilepsy. Epilepsia. https://doi.org/10.1111/j.1528-1157.1967.tb04428.x
238. Gull, D. G., & Langford, N. (2006). Drugs and driving. Adverse Drug Reaction Bulletin. https://doi.org/10.1097/00012995-200606000-00001
239. Gupta, T., Bhagat, S., & Gupta, S. (2005). INSOMNIA- AN INCREASING TREND IN PRESENT ERA. World Journal of Pharmaceutical and life sciences.
240. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
241. Guthrie, T. R. (2021). Other Health Impairment (OHI) Disabilities Category and an In-Depth Look at the Most Common Neurobiological Condition for Students. Advances in higher education and professional development book series. https://doi.org/10.4018/978-1-7998-7359-4.ch003
242. Gündoğmuş, İ., Karagöz, A., & Algül, A. (2018). First-episode psychosis induced by pregabalin withdrawal: a case report. Psychiatry and Clinical Psychopharmacology. https://doi.org/10.1080/24750573.2018.1452523
243. Hainline, B., Gurin, L., & Torres, D. M. (2019). Anxiety Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0016
244. Hainline, B., Gurin, L., & Torres, D. M. (2019). Migraine and Other Headache Disorders Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0014
245. Hainline, B., Gurin, L., & Torres, D. M. (2019). Unmasking Neuropsychiatric Disorders Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0035
246. Hall, S. W. (2011). Idiopathic Environmental Intolerances. SpringerReference. https://doi.org/10.1007/springerreference_44303
247. Ham, B., Seo, Y., & Kim, L. (2001). Acute Respiratory Distress due to Rapid Tranquilization in a Bipolar Patient with Sleep Apnea. Sleep Medicine and Psychophysiology.
248. Hamed, S. A. (2017). The auditory and vestibular toxicities induced by antiepileptic drugs. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2017.1372420
249. Hammeke, T. A., McQuillen, M. P., & Cohen, B. A. (1983). Musical hallucinations associated with acquired deafness.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.46.6.570
250. Hantson, P. (2004). Convulsions d'origine toxique. Réanimation. https://doi.org/10.1016/j.reaurg.2004.03.015
251. Hao, Y., Controzzi, M., Cipriani, C., Popović, D. B., Yang, X., Chen, W., Zheng, X., & Carrozza, M. C. (2013). Controlling hand-assistive devices: utilizing electrooculography as a substitute for vision. IEEE Robotics & Automation Magazine. https://doi.org/10.1109/mra.2012.2229949
252. Harding, S. (2005). Continuing Professional Development Managing delirium in older people.
253. Hasan, S., & D’Adamo, M. C. (2015). Episodic Ataxia Type 1.
254. Hayes, A., & Lingford‐Hughes, A. (2023). Drug Use, Addiction, Tolerance, Withdrawal and Relapse. Cambridge University Press eBooks. https://doi.org/10.1017/9781911623137.058
255. Heilman, K. M., Watson, R. T., & Valenstein, E. (2003). Neglect and Related Disorders. https://doi.org/10.1093/oso/9780195133677.003.0013
256. Henkin, R. I., & Abdelmeguid, M. (2020). Smell Loss and Onset of Phantosmia are Critical Aspects of Head Injury Cognition. The FASEB Journal. https://doi.org/10.1096/fasebj.2020.34.s1.02320
257. Hiraiwa, H., Hiraiwa, R., DATE, S., & Sakiyama, T. (2010). Muscle Hypertension, Excitation, and Insomnia, Possibly Related with the Administration of Bupleurum Root Containing Formulations, for 7 Cases of Severe Mental and Physical Disabilities, or Developmental Disorder. Kampo Medicine. https://doi.org/10.3937/kampomed.61.36
258. Hj, A., Barrucand, D., & Auzépy, P. (1993). [Alcohol withdrawal syndrome and delirium tremens. Their treatment].. PubMed.
259. Holcát, M. (2007). [Tinnitus and diabetes].. PubMed.
260. Holgate, S. T. (2002). Considerations on third generation antihistamines. Clinical & Experimental Allergy. https://doi.org/10.1046/j.1365-2222.2002.01339.x
261. Hollister, L. E. (1977). Withdrawal From Benzodiazepine Therapy. JAMA. https://doi.org/10.1001/jama.1977.03270410032003
262. Homnick, D. N. (2012). Dyspnea. Humana Press eBooks. https://doi.org/10.1007/978-1-61779-857-3_4
263. Hong, C. (2013). 분과 심포지움 2. 임상 : 새로운 진단체계 DSM-5; 조현병 스펙트럼 및 기타 정신병적 장애,성격장애. 한국심리학회 연차 학술발표논문집.
264. Hong-ya, S. (2014). Progress in the Prevention and Treatment of Disulfiram-like Reactions of Drugs. Chinese Journal of Drug Evaluation.
265. Hosztafi, S. (2011). [Heroin addiction].. PubMed.
266. House, S. A., & Fisher, E. L. (2017). Hoarseness in Adults.. PubMed.
267. Howard, A., Robbins-Welty, G. A., Schindler, N., Kincaid, B. M., & Komisar, J. (2024). Misdiagnosis of Primary Eating Disorder in an Individual With Major Depressive Disorder and Comorbid Catatonic Syndrome. Journal of Psychiatric Practice. https://doi.org/10.1097/pra.0000000000000825
268. Howland, R. H. (2015). Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/02793695-20150526-02
269. Hughes, J. R. (1999). Comorbidity and smoking. Nicotine & Tobacco Research. https://doi.org/10.1080/14622299050011981
270. Hughes, J. R., & Hatsukami, D. K. (1987). Criteria of a Pharmacologic Withdrawal Syndrome-Reply. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1987.01800160108017
271. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
272. Hȧrd, E., Archer, T., & Hansen, S. (2003). Animal Models of Mental Retardation. Humana Press eBooks. https://doi.org/10.1385/0-89603-177-2:273
273. Ilbeigi, M. S., Davidson, M., & Yarmush, J. (1998). An Unexpected Arousal Effect of Etomidate in a Patient on High-dose Steroids . Anesthesiology. https://doi.org/10.1097/00000542-199812000-00045
274. Irom, B. S. (2020). Is Mental Health Condition a Cause of Anxiety. Journal of Traumatic Stress Disorders & Treatment. https://doi.org/10.37532/2324-8947.2020.9(6).217
275. Isbell, H. (1956). ABUSE OF BARBITURATES. Journal of the American Medical Association. https://doi.org/10.1001/jama.1956.02970240042012
276. Isbell, H. (1956). Studies on Lysergic Acid Diethylamide (LSD-25). A M A Archives of Neurology & Psychiatry. https://doi.org/10.1001/archneurpsyc.1956.02330290012002
277. Isbell, H., & Fraser, H. F. (1950). ADDICTION TO ANALGESICS AND BARBITURATES. Pharmacological Reviews.
278. Isbell, H., & Fraser, H. F. (1950). ADDICTION TO ANALGESICS AND BARBITURATES. Pharmacological Reviews. https://doi.org/10.1016/s0031-6997(25)07083-8
279. Isbell, H., Belleville, R. E., Fraser, H. F., Wikler, A., & Logan, C. (1956). Studies on lysergic acid diethylamide (LSD-25).  I.  Effects in former morphine addicts and development of tolerance during chronic intoxication.. PubMed.
280. Isenberg, K., & Garcia, K. S. (2008). Syndromes of Brain Dysfunction Presenting with Cognitive Impairment or Behavioral Disturbance: Delirium, Dementia, and Mental Disorders Caused by a General Medical Condition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_2
281. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Psychedelics. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0606
282. İVECEN, B., & Gökdemir, Ö. (2022). Methamphetamine Addiction. DAHUDER Medical Journal. https://doi.org/10.56016/dahudermj.1184367
283. Jablensky, A. (2012). Course and outcome of schizophrenia and their prediction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0078
284. Jain, N., Himanshu, D., Verma, S., & Parihar, A. (2013). Methanol poisoning: characteristic MRI findings. Annals of Saudi Medicine. https://doi.org/10.5144/0256-4947.2012.26.5.1114
285. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
286. Jakl, M., Skořepa, P., & Horáček, J. M. (2016). IMPACT OF EXTREME PHYSICAL EXERCISE ON HUMAN BODY. Military Medical Science Letters. https://doi.org/10.31482/mmsl.2016.026
287. Janiani, A., Ali, T., Garg, G., Chaudhury, S., Javedekar, A., & Singh, A. (2024). Alcohol-induced psychotic disorder with hallucinations (alcoholic hallucinosis): A case series. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_310_23
288. Janicak, P. G. (2014). Pharmacological Treatment of Psychosis. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg11
289. Jargin, S. V. (2019). Some aspects of tobacco smoking in the context of alcohol drinking, hangover and mental health problems. International Journal of Psychiatry Research. https://doi.org/10.33545/26648962.2019.v1.i2a.10
290. Jeon, H. J. (2023). Clinical presentation, diagnosis, and treatment of sleep disorders in adolescents. Journal of Korean Medical Association. https://doi.org/10.5124/jkma.2023.66.4.258
291. Johansson, B., Andréll, P., Mannheimer, C., & Rönnbäck, L. (2022). [Mental fatigue - possible explanations, diagnostic methods and possible treatments].. PubMed.
292. Jonge, M. E. A.-D., Portier, C., & Franssen, E. J. F. (2007). [Automutilation after consumption of hallucinogenic mushrooms].. PubMed.
293. Judd, L. L., Schettler, P. J., Brown, E. S., Wolkowitz, O. M., Sternberg, E. M., Bender, B. G., Bulloch, K., Cidlowski, J. A., Kloet, E. R. D., Fardet, L., Joëls, M., Leung, D. Y., McEwen, B. S., Roozendaal, B., Rossum, E. F. C. V., Ahn, J., Brown, D. W., Plitt, A., & Singh, G. (2014). Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2014.13091264
294. Kalivas, P. W. (2003). Development and Expression of Behavioral Sensitization. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_9
295. Kalivas, P. W., Toda, S., Bowers, M. S., Baker, D. L., & Ghasemzadeh, M. B. (2003). The Temporal Sequence of Changes in Gene Expression by Drugs of Abuse. Humana Press eBooks. https://doi.org/10.1385/1-59259-358-5:03
296. Kalsi, S. S., Wood, D. M., & Dargan, P. I. (2011). The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerging Health Threats Journal. https://doi.org/10.3402/ehtj.v4i0.7107
297. Kam, J. C., Doraiswamy, V., Dieguez, J., Dabu, J., Cholankeril, M., Govind, M., Miller, R., & Adelman, M. (2013). Foreign Body Aspiration Presenting with Asthma-Like Symptoms. Case Reports in Medicine. https://doi.org/10.1155/2013/317104
298. Kamm, M. (2003). Constipation and its management. BMJ. https://doi.org/10.1136/bmj.327.7413.459
299. Kanyengo, C. W. (2009). Zambia: The challenge of informing blind and deaf clients.
300. Kap, Y. S. (2010). A Primate View on Multiple Sclerosis.
301. Karila, L., Roux, P., Rolland, B., Benyamina, A., Reynaud, M., Aubin, H., & Lançon, C. (2014). Acute and Long-Term Effects of Cannabis Use: A Review. Current Pharmaceutical Design. https://doi.org/10.2174/13816128113199990620
302. Karssemeijer, E. G., Heijden, C. D. V. D., Wolters, T. L. C., Boekhorst, B. T., Avest, M. T., & Kramers, C. (2021). [Don't stop medication too abruptly: advice about the discontinuation of medication]..
303. Karssemeijer, E. G., Heijden, C. D. V. D., Wolters, T. L. C., Boekhorst, B. T., Avest, M. T., & Kramers, C. (2021). [Don't stop medication too abruptly: advice about the discontinuation of medication].. PubMed.
304. Kayser, B., & Gremion, G. (2004). Chronic fatigue and loss of performance in endurance athletes: overtraining. Schweizerische Zeitschrift für Sportmedizin und Sporttraumatologie.
305. Kazymova, N., Kharlamenkova, N. Y., & Nikitina, D. A. (2019). Severe life events and their psychological consequences: loss or threat of loss of nearest. Vestnik Kostroma State University Series Pedagogy Psychology Sociokinetics. https://doi.org/10.34216/2073-1426-2019-25-2-96-101
306. Keary, C. J., Nejad, S. H., Rasimas, J. J., & Stern, T. A. (2013). Intoxications Associated With Agitation, Tachycardia, Hypertension, and Fever: Differential Diagnosis, Evaluation, and Management. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.12f01459
307. Keith, S. J. (2007). Dual Diagnosis of Substance Abuse and Schizophrenia: Improving Compliance with Pharmacotherapy. Clinical Schizophrenia & Related Psychoses. https://doi.org/10.3371/csrp.1.3.5
308. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
309. Kemp, S. F., & Lockey, R. F. (2010). Pathophysiology and Organ Damage in Anaphylaxis. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-951-2_3
310. Keyes, K. M., Pratt, C., Galea, S., McLaughlin, K. A., Koenen, K. C., & Shear, M. K. (2014). The Burden of Loss: Unexpected Death of a Loved One and Psychiatric Disorders Across the Life Course in a National Study. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2014.13081132
311. Khadse, V. S. C. (2022). Free Papers Compiled. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.341792
312. Khaikin, Y., & Mercimek‐Andrews, S. (2016). STXBP1 Encephalopathy with Epilepsy.
313. Khoo, C. S., Park, K. M., Lee, D., Lee, B. I., & Kim, S. E. (2020). A Case of a ‘Rude’ but Not to be Missed Manifestation of Epilepsy: Ictal Swearing. The Journal of the Royal College of Physicians of Edinburgh. https://doi.org/10.4997/jrcpe.2020.112
314. Kiecolt‐Glaser, J. K., Derry, H. M., & Fagundes, C. P. (2015). Inflammation: Depression Fans the Flames and Feasts on the Heat. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2015.15020152
315. Kintz, P., Villain, M., Cirimele, V., Goullé, J., & Ludes, B. (2002). [Crime under the influence of psychoactive drugs: the problem of the duration of detection].. PubMed.
316. Klein, S. (2015). Autistic phenomena in neurotic patients 1. Routledge eBooks. https://doi.org/10.4324/9781315743882-10
317. Kloft, L., Monds, L. A., Blokland, A., Ramaekers, J. G., & Otgaar, H. (2021). Hazy memories in the courtroom: A review of alcohol and other drug effects on false memory and suggestibility. Neuroscience & Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2021.02.012
318. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
319. Knight, E., & McIntyre, A. (2012). Pharmacy medications and driving: delivering key information to ageing drivers.
320. Knupp, K. G., & Wirrell, E. (2014). Progressive myoclonic epilepsies. Neurology. https://doi.org/10.1212/wnl.0000000000000091
321. Kondo, T., & Ishiguchi, H. (2007). 3. Drug Induced Dyskinesia. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.96.1621
322. Konez, O., Pascual-Castroviejo, I., Rocco, C. D., & Ruggieri, M. (2008). Sturge-Weber Syndrome. https://doi.org/10.1007/978-3-211-69500-5_10
323. Kontos, A. P., & McAllister-Deitrick, J. (2017). Concussion in Sport. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.175
324. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
325. KOYNER, F. G., Barrera, N. P., Subedi, P., Shrestha, K., & Cerrud‐Rodriguez, R. (2024). When Two Syndromes Collide: Managing Fanconi and Refeeding Syndrome in a Single Patient. Cureus. https://doi.org/10.7759/cureus.52169
326. Kramer, L. D., Locke, G. E., Ogunyemi, A. O., & Nelson, L. (1990). Cocaine-Related Seizures in Adults. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.3109/00952999009001592
327. Krishnan, J. (2024). MDMA (3,4-methylenedioxy-methamphetamine). BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/9789815223828124010004
328. Krishnan, J. (2024). Methamphetamine. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/9789815223828124010006
329. Ksiądzyna, D., Merwid‐Ląd, A., Matuszewska, A., Grotthus, B., & Szeląg, A. (2019). Objawy odstawienia wybranych leków. Część I. Medycyna Rodzinna. https://doi.org/10.25121/mr.2019.22.1.27
330. Ksiądzyna, D., Merwid‐Ląd, A., Matuszewska, A., Grotthus, B., & Szeląg, A. (2019). Objawy odstawienia wybranych leków. Część II. Medycyna Rodzinna. https://doi.org/10.25121/mr.2019.22.1.33
331. Kurvits, L., Mainka, T., Cavanna, A. E., Kühn, A. A., & Ganos, C. (2021). Aggression Toward Others Misdiagnosed as Primary Tics. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13236
332. Kusumadewi, A. F. (2020). Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication. Archives of The Medicine and Case Reports. https://doi.org/10.37275/amcr.v1i2.13
333. Kuypers, K. P. C. (2024). Microdosing psychedelics in the treatment of ADHD and comorbid disorders. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.44
334. Kızılkılıç, E. K., Kılboz, B. B., & Üçler, S. (2023). Syndrome of Transient Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): A Case Report - Is there an Association with the COVID-19 Vaccine?. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_1002_22
335. Lader, M., & Morris, R. G. (2001). Carbon Monoxide Poisoning. Journal of the Royal Society of Medicine. https://doi.org/10.1177/014107680109401029
336. Lahey, B. B. (2021). Dimensions of Externalizing Problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197607909.003.0004
337. Laliberte, B., & Kishk, O. A. (2017). Serotonin Syndrome in a Pediatric Patient After Vilazodone Ingestion. Pediatric Emergency Care. https://doi.org/10.1097/pec.0000000000001115
338. Lambert, T. (2007). Switching antipsychotic therapy: what to expect and clinical strategies for improving therapeutic outcomes.. PubMed.
339. Lane, H., Su, K., & Chang, W. (1999). Seizures After Discontinuation of Low-Dose Lorazepam From Originally Seizure-Free Clozapine Regimen. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v60n0611b
340. Laurent, B., & Garnier, P. (1993). [Neurologic emergencies in acute alcoholic intoxication].. PubMed.
341. Law, F., & Nutt, D. (2012). Drugs used in the treatment of the addictions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0158
342. Leal, J. L. V., Hoyos-Zuluaga, C., & Álvarez, J. Z. (2022). ¿Psicosis luego de sobredosis por opioides? Lesión isquémica bilateral del globo pálido como causa orgánica insospechada.. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v85i4.4371
343. Lee, C., Kim, T. Y., Song, Y. K., Son, Y., & Cheong, Y. K. (2006). Transient Global Amnesia Developed in Recovery Room following General Anesthesia: A case report. Korean Journal of Anesthesiology. https://doi.org/10.4097/kjae.2006.51.1.130
344. Lee, H., Kim, J., Lee, H.-S., Jo, Y.-H., Ko, J.-A., In, S., & Lee, J.-B. (2023). MS Fragmentation of ALD-52 with GC-MS and LC-QTOF. Korean Journal of Forensic Science. https://doi.org/10.53051/ksfs.2023.24.1.2
345. Lee, W. (2024). Potentially Fatal Parasomnia Suspected to be Caused by Zolpidem. Journal of Sleep Medicine. https://doi.org/10.13078/jsm.240005
346. Lehrer, P. M., Feldman, J., Giardino, N. D., Song, H.-S., & Schmaling, K. B. (2002). Psychological aspects of asthma.. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037//0022-006x.70.3.691
347. Lejoyeux, M., & Adès, J. (1993). [Psychiatric emergencies in acute alcoholic intoxication].. PubMed.
348. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
349. LEÓN-CARRIÓN, M. D. R. D. M. J. (2006). Low-level responsive states. Taylor & Francis eBooks. https://doi.org/10.4324/9780203965238-15
350. Lidija, G. G. S. (2011). Physiotherapeutic intervention with neurodevelopment risky infants in NICU.
351. Lieblich, S. E. (2015). Delayed Awakening from Anesthesia. https://doi.org/10.1002/9781119053231.ch40
352. Lim, H., Cho, Y. S., & Kim, H. J. (2008). Case Reports : A Case of Gluteal Myonecrosis Aggravated after Discharge by Intoxication with Several Drugs Including Tricyclic Antidepressants (TCA). 대한응급의학회지.
353. Liniya, S., Lakshmi, R., & Vijayalakshmi, S. (2014). DAPSONE INDUCED HYPERSENSITIVITY SYNDROME–A CASE REPORT. International Journal of Pharmacy and Pharmaceutical Sciences.
354. Lipowski, Z. J. (1987). Delirium (Acute Confusional States). JAMA. https://doi.org/10.1001/jama.1987.03400130103041
355. Liu, C., Tseng, A., & Yang, S. (2004). Chinese Herbal Medicine: Modern Applications of Traditional Formulas.
356. Llcms, L. C., Martins, P. R. C., Loures, É. N., Vitalino, A. R., Lotufo, C. C., & Onady, S. Y. (2017). ATAQUE ISQUÊMICO TRANSITÓRIO E ESTADO DE MAL EPILÉPTICO COMO MANIFESTAÇÕES DE INTOXICAÇÃO AGUDA E ABSTINÊNCIA POR CRACK E COCAÍNA.
357. Logan, B. K., & Couper, F. J. (2003). 3,4-Methylenedioxymethamphetamine - Effects on Human Performance and Behavior.. PubMed.
358. López, A. M., Martínez, L. R. D., & Moreno, J. (2012). Uso de marcadores bioquímicos para valoración de riesgo de crisis convulsivas en el síndrome de supresión etílica. Salud Mental.
359. Macenski, C. L. (2021). Recurrent episodes of intense fear, shortness of breath, racing heart, and sweating. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197577479.003.0014
360. Macho, L. P., & Andrés, S. B. (2010). Trastornos digestivos en la enfermedad de Parkinson: atonía gástrica, malabsorción y estreñimiento. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009740
361. Macias, C., Montaño, M. G., & Vega, D. (2015). Differential Diagnosis Between Neuroleptic Malignant Syndrome and Catatonia. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30515-0
362. Madhavan, S. (2015). Complications of General Anesthetics and its Management. Research Journal of Pharmacy and Technology. https://doi.org/10.5958/0974-360x.2015.00174.2
363. Magalhães, E., Campos, R., Sarin, L. M., & Porto, J. A. D. (2016). First episode of bipolar depression and suicide attempt after bariatric surgery in a 45-year-old woman. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1176
364. Mahadevan, J., D’cruz, M., Chand, P., & Murthy, P. (2019). An interesting presentation of psychotic catatonia in an elderly patient with alcohol dependence. Journal of Geriatric Mental Health. https://doi.org/10.4103/jgmh.jgmh_33_19
365. Mahato, A. N., Mudaliyar, S., & Azad, S. C. (2024). Pseudobulbar affect masquerading as psychosis: Managing a case of diagnostic dilemma. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_117_24
366. Mahato, T. K., Ojha, S. K., Singh, V., & Parihar, S. P. S. (2021). Addiction withdrawal syndrome: Needs medications, education, counselling &amp; support. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2021.12.2.0573
367. Malenfant, M., Tremblay, S., Laurin, D., & Lefèbvre, J. (2008). L'utilisation du citalopram pour traiter l'agitation et les symptômes psychotiques chez les patients souffrant de démence.
368. Maltinsky, W., Henton, S., Spaltro, G., Fowler, S. J., Chaudhuri, R., Higgs, C., Boiskin, D., & Preece, S. (2024). Illness perceptions, symptom severity and psychosocial outcomes in adults with dysfunctional breathing. Journal of Asthma. https://doi.org/10.1080/02770903.2024.2397656
369. Manjunatha, N., Vidyendaran, R., Rao, M., Kulkarni, G. B., Muralidharan, K., John, J. P., Amar, B. R., & Jain, S. (2010). Subacute vocal cord paralysis, facial palsy and paraesthesias of lower limbs following surreptitious administration of disulfiram. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2009.190397
370. Manschreck, T. C. (1996). Delusional disorder: the recognition and management of paranoia.. PubMed.
371. Manuchehri, A. A., Alijanpour, E., Daghmechi, M., Ghaeminan, N., Abedi, S. H., Nikbakhsh, N., Saeed, S. A. M. G. M., & Amani, N. (2015). A case of methanol poisoning leading to prolonged respirator dependency with consequent blindness and irreversible brain damage.. PubMed.
372. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
373. Marchesi, C., Tonna, M., & Maggini, C. (2008). Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622970701459828
374. Marconi, J., Fink, K., & Moya, L. E. O. (1967). Experimental Study on Alcoholics with an “Inability to Stop”. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.113.498.543
375. Maremmani, I., Pacini, M., Lamanna, F., Pani, P., Perugi, G., Deltito, J., Salloum, I. M., & Akiskal, H. S. (2010). Mood Stabilizers in the Treatment of Substance Use Disorders. CNS Spectrums. https://doi.org/10.1017/s1092852900027346
376. Martinotti, G., Petta, G. D., Piro, T., Chillemi, E., & Ferro, F. M. (2024). The exogenous model of psychotic experience induced by novel psychoactive substances: A clinical overview. Emerging Trends in Drugs Addictions and Health. https://doi.org/10.1016/j.etdah.2023.100141
377. Martins, J. R. D. S., Vaz, R., Costa, A., Brás, J., Sousa, R., Abreu, J., Almeida, E., Andrade, R., Castro, N., & Casanova, T. (2023). Postpartum Delirium: A Psychosis Born in the 18th Century. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2398
378. Martínez‐Castrillo, J. C., Vela, L., Val, J. D., & Alonso‐Cánovas, A. (2011). Nonmotor Disorders and Their Correlation With Dopamine. The Neurologist. https://doi.org/10.1097/nrl.0b013e318239669f
379. Martínez‐Salio, A., Soler-Algarra, S., Calvo-Garcia, I., & Sánchez-Martín, M. (2007). Síndrome de ingesta nocturna relacionada con el sueño con respuesta al topiramato. Revista de Neurología. https://doi.org/10.33588/rn.4505.2007188
380. María, A., Sancho, R., & Pita, B. L. (2005). Trastornos de ansiedad en la infancia y en la adolescencia.
381. Masoodi, S. A., & Maqbool, P. S. (2017). Posttraumatic Growth through Quran and Sunna: Islamic Perspective. International Journal of Indian Psychology. https://doi.org/10.25215/0402.065
382. Matsuoka, M. (2007). [Neurotoxicity of organic solvents--recent findings].. PubMed.
383. Mattous, M., Jbili, N., Bibiche, L., & Laoutid, J. (2020). Profound Hypoglycemia and Convulsion, Think About Ecstasy Poisoning. Scholars Journal of Medical Case Reports. https://doi.org/10.36347/sjmcr.2020.v08i02.046
384. Mauri, M. C. (2016). Drug Induced Psychosis or Schizophrenia?. Dual Diagnosis Open Access. https://doi.org/10.21767/2472-5048.100011
385. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
386. McArdle, P., & Angom, B. (2012). Adolescent substance misuse: an update on behaviours and treatments. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.bp.106.003327
387. McCarty, R. (2020). Stress and Schizophrenia. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190697266.003.0008
388. McInnis, M. G. (2014). Lithium for Bipolar Disorder: A Re Emerging Treatment for Mood Instability: Low Dosage, Slow Titration Might Mitigate Side Effects. Current psychiatry.
389. McIntosh, C., & Ritson, B. (2001). Treating depression complicated by substance misuse. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.7.5.357
390. McIntyre, R. S., & Calabrese, J. R. (2019). Bipolar depression: the clinical characteristics and unmet needs of a complex disorder. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2019.1636017
391. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
392. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
393. Meena, D., Chand, S., & Kumar, D. (2019). A Review Article on Selective Serotonin Reuptake Inhibitors (SSRIS). Asian Journal of Pharmaceutical Research and Development. https://doi.org/10.22270/ajprd.v7i6.592
394. Meggs, W. J., Pescovitz, O. H., Metcalfe, D. D., Loriaux, D. L., Cutler, G. B., & Kaliner, M. (1984). Progesterone Sensitivity as a Cause of Recurrent Anaphylaxis. New England Journal of Medicine. https://doi.org/10.1056/nejm198411083111907
395. Mehta, U. M., Kumar, C. N., Venkatasubramanian, G., & Thirthalli, J. (2013). Multimodal Sensory Distortions in Postpartum Exacerbation of Schizophrenia. Clinical Schizophrenia & Related Psychoses. https://doi.org/10.3371/csrp.meku.112013
396. Melo-Dias, C., Apóstolo, J., & Cardoso, D. (2014). Effectiveness of progressive muscle relaxation training for adults diagnosed with schizophrenia: a systematic review protocol. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/jbisrir-2014-1639
397. Mercês, T. M. D. (2019). Controle hidroeletrolítico e respostas cardiovasculares à injeção central de angII, carbacol e hiperosmolaridade plasmática em ratos com epilepsia induzida por pilocarpina.
398. Messouak, O., Boujraf, S., Chaouki, S., & Belahsen, F. (2008). Delayed onset dystonia secondary to neonatal anoxia..
399. Michael, D. M., Branford, D., & Barrett, M. J. (2015). Bipolar Affective Disorder. https://doi.org/10.1002/9781118897164.ch16
400. Michel, J., Gisselbaek, A., Gauthey, L., & Zelger, G. L. (1993). [Non-compliant drug taking in elderly subjects].. PubMed.
401. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395
402. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395_update_001
403. MINEI, S., Kainuma, M., Sakamoto, H., Tamaki, N., TOMORI, H., CHOLSONG, Y., Nakahara, Y., & FURUSSYO, N. (2019). Consideration of a New Category of Patients for Whom Ryokeijutsukanto is Effective at a Different Stage Then was Previously Reported. Kampo Medicine. https://doi.org/10.3937/kampomed.70.141
404. Mir, J. A., Mushtaq, B., & Mushtaq, O. A. (2022). Clinical case report on bipolar affective disorder, mania. IP Journal of Paediatrics and Nursing Science. https://doi.org/10.18231/j.ijpns.2022.007
405. Miyasato, K. (2013). [Psychiatric and psychological features of nicotine dependence].. PubMed.
406. Mizukami, K., Naito, Y., Yoshida, M., Nakanishi, T., & Koizumi, J. (1990). Mental Disorders Induced by Carbamazepine. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.1990.tb00441.x
407. Modebelu, U., Nargarathan, P. K. M., Marleime, K., & Ramesh, K. (2019). Pharmacologic Therapy for Neonatal Abstinence Syndrome. Journal of Drug Delivery and Therapeutics. https://doi.org/10.22270/jddt.v9i3.2900
408. Moh, D., & Sansone, R. A. (2015). Factitious Disorder Manifesting as Hematemesis and Hematochezia. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.14l01693
409. Monteiro, M. I., Ferreira, A., Grebe, H., Gomes, L., & Costa, M. M. D. (2016). Psiquiátrico, aditivo ou orgânico:  um desafio nos adolescentes. DOAJ (DOAJ: Directory of Open Access Journals).
410. Monti, M. M., Laureys, S., & Owen, A. M. (2010). The vegetative state. BMJ. https://doi.org/10.1136/bmj.c3765
411. Moore, D. P., & Puri, B. K. (2012). Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience 3E.
412. Morales, D. O. (2019). Muerte encefálica en pediatría..
413. Morgan, W. P. (1983). Hyperventilation Syndrome: A Review. AIHAJ. https://doi.org/10.1080/15298668391405562
414. Morin, C. (2009). [Sense of personal identity and focal brain lesions].. PubMed. https://doi.org/10.1684/pnv.2009.0156
415. Morylowska-Topolska, J., Ziemiński, R., Molas, A., Gajewski, J., Flis, M., Stelmach, E., & Karakuła‐Juchnowicz, H. (2016). Schizophrenia and anorexia nervosa – reciprocal relationships. A literature review. Psychiatria Polska. https://doi.org/10.12740/pp/onlinefirst/63514
416. Moshé, S. L., & Galanopoulou, A. S. (2018). Commentary on Schotte et al. “Development of temporal lobe epilepsy during maintenance electroconvulsive therapy: A case of human kindling?”. Epilepsia Open. https://doi.org/10.1002/epi4.12296
417. Mukim, M., Devi, S. L., Sharma, P., Joshef, M. R., Nagar, J. C., & Ahmad, N. (2019). ANESTHESIA AND ITS APPPLICATION. Indian Research Journal of Pharmacy and Science. https://doi.org/10.21276/irjps.2019.6.4.5
418. Munro, A. (1999). Delusional Disorder: Paranoia and Related Illnesses.
419. Munster, B. C. V., Rooij, S. E. D., & Inouye, S. K. (2016). Delirium, drugs, toxins. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199655946.003.0022
420. Murakami, M., Maruoka, S., & Miura, K. (2012). [Application and indication of psychotropic drugs for respiratory diseases].. PubMed.
421. Muñoz-Lara, J. (2015). Depresión en la persona adulta mayor institucionalizada: Un nuevo reto. Revista Hispanoamericana de Ciencias de la Salud (RHCS).
422. Müller, D., Angerer, V., Kithinji, J., Auwärter, V., Neurath, H., Liebetrau, G., Just, S., & Hermanns‐Clausen, M. (2016). Desoxypipradrol – eine neue (alte) Designerdroge. DMW - Deutsche Medizinische Wochenschrift. https://doi.org/10.1055/s-0042-107537
423. Müller, K., Gehl, A., Ottens, R., & Püschel, K. (2011). [Suicide by hypothermia with intentional partial undressing].. PubMed.
424. Na, I., & Volel, B. A. (2002). [Clinical aspects of "folie du doute"].. PubMed.
425. Naguy, A., Samir, P., & Al-Tajali, A. (2015). ECT for refractory secondary tourettism with dermatillomania following CO poisoning. Journal of Psychiatry and Brain Functions. https://doi.org/10.7243/2055-3447-2-2
426. Naidoo, S. (2015). Managing stress in the dental environment.
427. Naidu, B. M. (2016). Drug Abuse in India. International journal of research in social sciences.
428. Narayan, S. K., Sivaprasad, P., Sahoo, R. N., & Bhuvaneswari, V. (2008). Teaching Video Neuro <i>Image</i> : Chvostek sign with Fahr syndrome in a patient with hypoparathyroidism. Neurology. https://doi.org/10.1212/01.wnl.0000336974.93499.ad
429. Nass, R. (1992). Developmental Dyslexia: An Update. Pediatrics in Review. https://doi.org/10.1542/pir.13.6.231
430. Nelson, A., & Lewis, A. (2017). Determining Brain Death: Basic Approach and Controversial Issues. American Journal of Critical Care. https://doi.org/10.4037/ajcc2017540
431. Nelson, J. R., & Knox, J. W. (1966). Permanent Encephalopathy from Toluene Inhalation. New England Journal of Medicine. https://doi.org/10.1056/nejm196612292752608
432. Neufeld, K. J., Needham, D. M., Oh, E. S., Wilson, L. M., Nikooie, R., Zhang, A., Koneru, M., Balagani, A., Singu, S., Aldabain, L., & Robinson, K. A. (2019). Antipsychotics for the Prevention and Treatment of Delirium. https://doi.org/10.23970/ahrqepccer219
433. Nicolson, G. L., Nasralla, M. Y., Haier, J., & Nicolson, N. L. (1999). GULF WAR ILLNESSES: ROLE OF CHEMICAL, RADIOLOGICAL AND BIOLOGICAL EXPOSURES.
434. Oh, S.-H. (2019). 12 - CAN RORSCHACH DIFFERENTIATE BIPOLAR DISORDER FROM DEPRESSIVE DISORDER? : COMPARISON OF RORSCHACH SCORES BETWEEN BIPOAR DEPRESSION AND UNIPOLAR DEPRESSION. https://doi.org/10.26226/morressier.5d1a038757558b317a13f97e
435. Ohta, T. (1996). [Recent progress in development of psychotropic drugs (5)--Hypnotics].. PubMed.
436. Ojimba, C., Isidahome, E. E., Odenigbo, N., Umudi, O. D., & Olayinka, O. (2019). Catatonia in major depressive disorder: diagnostic dilemma. A case report. Journal of Psychology & Clinical Psychiatry. https://doi.org/10.15406/jpcpy.2019.10.00651
437. Olmedo, A., & Rolando, M. (2015). Informe psicológico pericial: situación de violencia intrafamiliar, “maltrato física, psicológica y sexual”, grado de afectación psicológico..
438. Olmos-López, A., Ibarra-Aguilar, J., Cornelio-Nieto, J. O., Ocaña-Hernández, L. A., Márquez-Amaya, M. A., Luna-López, N. A., Reséndiz-Aparicio, J. C., & Rodríguez‐Leyva, I. (2019). Clinical guideline: status epilepticus in children and adults. DELETED. https://doi.org/10.24875/rmn.m19000031
439. OLSEN, A., Olsen, L., & SCHNEIDERMAN, D. (2012). Loft Chilling Syndrome, or Thus Aunt Denis. Fairy Tale Review. https://doi.org/10.1353/fair.2012.a812872
440. Orme, S., & Harari, D. (2020). Bladder and bowels. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0060
441. Ortiz, S. R., Carrillo-Albornoz, E. J. O., & Coque, J. A. R. (2016). La intervención policial con sujetos confuso-agitados: El denominado “delirio agitado”. Cuadernos de la Guardia Civil: Revista de seguridad pública.
442. Otahbachi, M., Çevik, C., Bagdure, S., & Nugent, K. (2010). Excited Delirium, Restraints, and Unexpected Death. American Journal of Forensic Medicine & Pathology. https://doi.org/10.1097/paf.0b013e3181d76cdd
443. Otsuka, K., Kato, S., Abe, T., SUGIYAMA, H., Watanabe, Y., Kobayashi, T., & Okajima, Y. (2002). [Classification of long-term clinical course of 'atypical psychosis': a 20-year follow-up study at a medical school hospital].. PubMed.
444. Owen, R. T. (2006). Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: A review. Drugs of today. https://doi.org/10.1358/dot.2006.42.3.953589
445. Ownby, R. L. (2006). Medication adherence and cognition. Medical, personal and economic factors influence level of adherence in older adults.. PubMed.
446. Padmos, R. C. (2009). Inflammatory Monocytes in Bipolar Disorder and Related Endocrine Autoimmune Diseases.
447. Page, R. D. (1983). Cerebral dysfunction associated with alcohol consumption.. PubMed.
448. Page, R. M. (2014). Substance Abuse and Adolescent Psychological Distress. The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society. https://doi.org/10.1002/9781118410868.wbehibs433
449. Pal, H., Kumar, R., Bhushan, S., & Berry, N. (2005). Psychiatric co-morbidity associated with pheniramine abuse and dependence. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.46079
450. Palmer, B. W., McClure, F. S., & Jeste, D. V. (2001). Schizophrenia in Late Life: Findings Challenge Traditional Concepts. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220127883
451. Pang, N. T. P., & Masiran, R. (2020). Mood disorder induced by prednisolone – an easily overlooked complication. Current Problems of Psychiatry. https://doi.org/10.2478/cpp-2020-0012
452. Parrott, A. (2015). The Adverse Psychiatric Consequences of Recreational Stimulant Drugs Such as Methamphetamine, Cocaine, Ecstasy/mdma, and Mephedrone: a Unified Psychobiological Explanation.. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30842-7
453. Parsa, A., Mohammadkhan, A., & Babaeian, M. (2017). Zolpidem-Induced Narcolepsy, Faint, Seizure or Coma? A Case Report. Case Reports in Clinical Medicine. https://doi.org/10.4236/crcm.2017.62004
454. Patel, A., Moreland, T., Haq, F., Siddiqui, F., Mikul, M., Qadir, H., & Raza, S. (2011). Persistent Psychosis After a Single Ingestion of “Ecstasy” (MDMA). The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01200
455. Paulin, L. F. R. D. S., Reis, E. F. D., & Rodrigues, E. P. (2008). Síndrome de descontinuação dos antidepressivos.
456. Pechnick, R. N., Cunningham, K. A., & Danovitch, I. (2014). Hallucinogen-Related Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg51
457. Peitl, M. V., Prološčić, J., Zelić, S. B., Skarpa-Usmiani, I., & Peitl, V. (2011). Symptoms of agitated depression and/or akathisia.. PubMed.
458. Pendergraft, W. F., Herlitz, L., Thornley‐Brown, D., Rosner, M. H., & Niles, J. L. (2014). Nephrotoxic Effects of Common and Emerging Drugs of Abuse. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.00360114
459. Pereira, S. M. P., Guimarães, S. K. G., Marques, A., & Borges, S. (2008). Electroconvulsivotherapy in the elderly, indications, risks and side-effects. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2008.01.611
460. Perrott, J., & Burry, L. (2015). Has the Drug of Choice for Treating Critical Illness Delirium Been Established?. The Canadian Journal of Hospital Pharmacy. https://doi.org/10.4212/cjhp.v68i5.1494
461. Perry, E., Mosimann, U. P., & Collerton, D. (2014). The treatment of visual hallucinations at present and in the future. https://doi.org/10.1002/9781118892794.ch14
462. Persinger, M. A. (2016). Answers to Two Questions Consistently Reflect Cerebral Dysfunction or Damage Subsequent to Mild Closed Head Injuries and Protracted Difficulties with Adaptation. Journal of Neurological Disorders. https://doi.org/10.4172/2329-6895.1000277
463. Perłowski, J., Miśkiewicz, M., Ptak, J., Noga, R., Teska, V., Marcinkowska, J., Herc, A., Koczkodon, K., Sawczuk, M., & Krompiewski, M. (2024). Recreational ketamine use and its impact on health. Journal of Education Health and Sport. https://doi.org/10.12775/jehs.2024.68.55185
464. Petit, J., & Sansone, R. A. (2011). A Case of Interdose Discontinuation Symptoms With Venlafaxine Extended Release. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01140
465. Petkar, S., Jackson, M., & Fitzpatrick, A. (2005). Management of blackouts and misdiagnosis of epilepsy and falls. Clinical Medicine. https://doi.org/10.7861/clinmedicine.5-5-514
466. Phu, T., Remmers, A., Schytz, H. W., Schankin, C. J., Nelson, S. E., Obermann, M., Hansen, J. M., Sinclair, A. J., Gantenbein, A. R., & Schoonman, G. (2018). Red and orange flags for secondary headaches in clinical practice. Neurology. https://doi.org/10.1212/wnl.0000000000006697
467. Piacentini, J., & Bennett, S. M. (2010). Tourette's Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1001
468. Piccolo, A. C., Campos, L. M. G., & Audi, M. (2025). RELAÇÃO ENTRE A QUALIDADE DO SONO, PERCEPÇÃO CORPORAL E OS SINTOMAS MOTORES E SENSITIVOS EM PESSOAS COM ESCLEROSE MÚLTIPLA REMITENTE-RECORRENTE. Aracê.. https://doi.org/10.56238/arev7n8-002
469. Pich, E. M., Heidbreder, C., Mugnaini, M., & Teneggi, V. (2003). Molecular and Behavioral Aspects of Nicotine Dependence and Reward. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_16
470. Pichler, W. J., & Pichler, C. E. (2009). DRESS (Drug Rash with Eosinophilia and Systemic Symptoms). Allergologie. https://doi.org/10.5414/alp32365
471. Pikirenia, U., Fedotov, I., Tuchina, O., & Kapytau, A. U. (2017). Cognitive impairment due to alcohol abuse: current status of research. Vestnik of Saint Petersburg University Medicine. https://doi.org/10.21638/11701/spbu11.2017.306
472. Pimiento, A. P., Parra, B. F., Montoya, M. S., Arranz, S., & Domínguez, A. R. (2001). Síndrome de anafilaxia inducida por ejercicio. Anales de Medicina Interna. https://doi.org/10.4321/s0212-71992001000500010
473. Piątek, A., Koziarska-Rościszewska, M., & Zawilska, J. B. (2015). Rekreacyjne używanie leków dostępnych w odręcznej sprzedaży: odurzanie i doping mózgu. Alcoholism and Drug Addiction. https://doi.org/10.1016/j.alkona.2015.03.001
474. Plavec, D., & Vuljanko, I. M. (2010). ANAFILAKSIJA POTAKNUTA NAPOROM.
475. Plotkin, K. E. (2007). Insomnia Caused by Medical Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-042-7_15
476. Plucar, B., & Vávrů, I. (2005). Depression and antidepressants. Kontakt. https://doi.org/10.32725/kont.2005.065
477. Pollanen, M. S. (2017). The pathology of torture. Forensic Science International. https://doi.org/10.1016/j.forsciint.2017.12.022
478. Pomerantz, J. M. (2008). Early Antidepressant Treatment Is Effective for Post-Stroke Depression.
479. Pontius, A. A. (1993). Neuropsychiatric Update of the Crime “Profile” and “Signature” in Single or Serial Homicides: Rule out Limbic Psychotic Trigger Reaction<sup>1</sup>. Psychological Reports. https://doi.org/10.1177/00332941930733pt125
480. Popescu, D., Popescu, G., Lupu, G., Panus, V., Neagu-Sadoveanu, S., & Buda, O. (2010). Drugs effects on the central nervous system. Forensic implications. Romanian Journal of Legal Medicine. https://doi.org/10.4323/rjlm.2010.231
481. Potvin, O., Hudon, C., Grenier, S., & Préville, M. (2010). Non-essential symptoms of depression and cognitive impairment no dementia (CIND) in community-dwelling elders without dysphoria or anhedonia. International Psychogeriatrics. https://doi.org/10.1017/s1041610210001419
482. Pounder, D. J., Karch, S. B., & Stephens, B. G. (1998). Acute excited states and sudden death. BMJ. https://doi.org/10.1136/bmj.316.7138.1171
483. Prabha, Y. S. (2023). Stress as a Topic of Concern in Gut Health: A Review. UTTAR PRADESH JOURNAL OF ZOOLOGY. https://doi.org/10.56557/upjoz/2023/v44i123527
484. Prajapati, B., Agarwal, A., Garg, D., Garg, A., Pandit, A., Radhakrishnan, D. M., & Srivastava, A. (2024). Delayed post-hypoxic parkinsonism with leukoencephalopathy associated with carbon monoxide poisoning. Annals of Movement Disorders. https://doi.org/10.4103/aomd.aomd_37_24
485. Prasad, K., Prasad, M., Ramaratnam, S., & Marson, A. G. (2015). Status epilepticus. https://doi.org/10.1002/9781119067344.ch9
486. Pratibha, S. (2010). Etiology of Late Onset Seizures.
487. Provini, F., Lombardi, C., & Lugaresi, E. (2005). Insomnia in Neurological Diseases. Seminars in Neurology. https://doi.org/10.1055/s-2005-867074
488. Pujol, R., & Puel, J. (1999). Excitotoxicity, Synaptic Repair, and Functional Recovery in the Mammalian Cochlea: A Review of Recent Findings. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1999.tb08646.x
489. Pérez, F. C. (2004). Efectos a largo plazo de la exposición aguda a compuestos organofosforados.
490. Pérez, J. M. C. (2003). Clínica de la adicción a pasta base de cocaína. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272003000100007
491. Pérez, Y. M. M., Ortega, D. L. G., & Torres, S. V. L. (2022). AGITACIÓN PSICOMOTRIZ. PUERTO MADERO EDITORIAL eBooks. https://doi.org/10.55204/pmea.3.c10
492. Păunica, S., Giurgiu, M., Vasilache, A., Păunică, I., Motofei, I. G., Vasilache, A., Dumitriu, H., & Dumitriu, A. S. (2016). Finasteride adverse effects and post-finasteride syndrome; implications for dentists. Journal of Mind and Medical Sciences. https://doi.org/10.22543/2392-7674.1039
493. Płytycz, B., & Seljelid, R. (2002). Stress and immunity: minireview.. PubMed.
494. Quintero, J. M. B., Castellanos, A., & Santos, L. S. D. L. (2018). Efectividad de una intervención pre-quirúrgica de enfermería; en ansiedad de pacientes sometidos a colecistectomía del Hospital General Regional No.1 Vicente Guerrero de Acapulco, 2017.
495. Qureshi, M. A., & Wasti, S. A. (2014). Lay-off Survivor Sickness Syndrome (Investigating the Lasting Impact on Performance of Survivors in the Context of Age and Gender in Private Sector Organizations of Pakistan). International Journal of Human Resource Studies. https://doi.org/10.5296/ijhrs.v4i3.6078
496. Radovanovi, M. R., Milovanovi, D. R., & Radovanovi, M. S. (2012). Heroin addict with gangrene of the extremities, rhabdomyolysis and severe hyperkalemia Heroinski zavisnik sa gangrenom ekstremiteta, rabdomiolizom i teškom hiperkalemijom.
497. Raff, H., & Zhang, C. D. (2023). A New Approach — Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency. NEJM Evidence. https://doi.org/10.1056/evide2200306
498. Rahmani, M., Ahmadi, S., & Moghaddam, H. H. (2011). Serotonin Syndrome Following Single Ingestion of High Dose.
499. Rahmani, S. H. (2011). Serotonin Syndrome Following Single Ingestion of High Dose Methamphetamine. Journal of Clinical Toxicology. https://doi.org/10.4172/2161-0495.1000111
500. Raičević, B., Janković, S. V., Gojak, R., Dabanović, V., & Јаnkovic, S. (2023). Long-term outcomes in refractory status epilepticus. Expert Review of Neurotherapeutics. https://doi.org/10.1080/14737175.2023.2292143
501. Ramos, B. R. M., Martins, F. S., & Osório, E. (2022). Psychotic Cannabis Withdrawal: A Clinical Case. Cureus. https://doi.org/10.7759/cureus.31465
502. Ranganathan, A., & Beitman, B. D. (1998). Panic disorder: a different perspective.. PubMed.
503. Rani, S., & Saini, D. S. (2015). Organizational Stress in Relation to Job Satisfaction and General Health of Professional Women. International journal of education and management studies.
504. Rao, S. (2016). Prolonged coma after anesthesia. Journal of Anaesthesiology Clinical Pharmacology. https://doi.org/10.4103/0970-9185.173339
505. Rao, T. S., & Kumar, M. A. (2008). Agenda for specialty section in addiction medicine. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.44741
506. Rastegar, D. A., & Fingerhood, M. (2015). Cocaine, Methamphetamine, and Other Stimulants. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214647.003.0008
507. Rastegar, D. A., & Fingerhood, M. (2015). Hallucinogens and Dissociatives. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214647.003.0009
508. Reddy, S., Elsayem, A., & Talukdar, R. (2005). Palliative Care. CRC Press eBooks. https://doi.org/10.1201/b14119-59
509. Reuber, M., Schachter, S. C., Elger, C. E., & Altrup, U. (2009). Conditions Associated With Epilepsy. https://doi.org/10.1093/oso/9780195379532.003.0005
510. Rietveld, S. (1998). Symptom Perception in Asthma: A Multidisciplinary Review. Journal of Asthma. https://doi.org/10.3109/02770909809068201
511. Rigaud, J., Lheureux, P., & Sauder, P. (2006). Prise en charge symptomatique : neurologique, respiratoire, hémodynamique et hépatique des intoxications graves par médicaments et substances illicites. Réanimation. https://doi.org/10.1016/j.reaurg.2006.08.002
512. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
513. Rizvi, N., Whitty, M., & Daly, R. J. (2010). Absinthe and suicidality. Irish Journal of Psychological Medicine. https://doi.org/10.1017/s0790966700000914
514. Robertson, M. M., & Cavanna, A. E. (2008). What other disorders can be mistaken for Tourette syndrome?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199298198.003.0005
515. Robison, D., & Hunt, S. D. (2005). Sudden In-Custody Death Syndrome.
516. Rodrigo, M. L., Monge, M. P., Fominaya, M. P., Oliver, A. O., Guerra, M. T., Montero, C. G., & Font, V. R. (2022). Two of us live in this body. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.2256
517. Rodríguez, E. O., Esquivel, P. S., & Triana, I. M. (2024). Un panorama actualizado de la dispepsia. Revista médica de Panamá. https://doi.org/10.37980/im.journal.rmdp.20242296
518. Rodríguez, E. O., Martı́nez-Raga, J., Gómez, M. C., Gálvez, B. P., Ferragut, A. S., & Martínez, G. C. (2003). Complicaciones físicas del consumo de drogas recreativas. Adicciones. https://doi.org/10.20882/adicciones.462
519. Roland, P. S., & Blau, P. (2016). Diagnosis and Management of Balance Disturbances Following Traumatic Brain Injury. CRC Press eBooks. https://doi.org/10.1201/9781439849828-10
520. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
521. Rosebush, P. I., & Mazurek, M. F. (2007). Catatonia. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-960-8_8
522. Roth, T., Krystal, A. D., & Lieberman, J. A. (2007). Long-term issues in the treatment of sleep disorders.. CNS Spectrums.
523. Rotunda, R. J., Herzog, J. R., Dillard, D. R., King, E., & Wilson, K. O. (2024). Alcohol Misuse and Correlates with Mental Health Indicators among Firefighters. Substance Use & Misuse. https://doi.org/10.1080/10826084.2024.2422975
524. Rowe, J. B. (2010). Conversion disorder: understanding the pathogenic links between emotion and motor systems in the brain. Brain. https://doi.org/10.1093/brain/awq096
525. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
526. Roy, B. A. (2015). Overreaching/Overtraining. ACSMʼs Health & Fitness Journal. https://doi.org/10.1249/fit.0000000000000100
527. Rubiales, Á. S., Duarte, F. J. B., & Valle, M. L. D. (2015). Es necesario precisar el concepto de sedación. Cuadernos de bioética/Cuadernos de bioética.
528. Rubin, D., McAbee, G. N., & Feldman‐Winter, L. (2002). Auditory Hallucinations Associated With Migraine. Headache The Journal of Head and Face Pain. https://doi.org/10.1046/j.1526-4610.2002.02153.x
529. Runge, U., Hintze, U., Hachenberg, T., & Wendt, M. (1998). Dissoziativer Stupor -eine Differentialdiagnose des Komas nach Unfällen. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. https://doi.org/10.1055/s-2007-994846
530. Ružić, M. (2016). Poremećaj glasa kod osoba treće životne dobi.
531. Río, J. A. D. (2013). Incapacitación y drogodependencias.
532. Saad, S., Shaboob, E., & Alwakeel, Z. (2020). Anesthetic Considerations in Epilepsy. Benha Journal of Applied Sciences. https://doi.org/10.21608/bjas.2020.135407
533. Sabo-Graham, T., & Seay, A. R. (1998). Consultation with the Specialist: Management of Status Epilepticus in Children. Pediatrics in Review. https://doi.org/10.1542/pir.19.9.306
534. Sadikin, A., & Linda, N. (2018). PENYALAHGUNAAN NARKOBA DAN PSIKOTROPIKA DI KALANGAN REMAJA.
535. Saeed, M. A. A. (2017). Management of tinnitus patient. International Journal of Growth and Development. https://doi.org/10.25081/ijgd.2017.v1i1.44
536. Saeed, S. A., & Tj, B. (1998). Panic disorder: effective treatment options.. PubMed.
537. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
538. Sahu, D., Garg, J., & Anand, K. S. (2023). An Interesting Case of Eating Epilepsy. Indian Journal of Medical Specialities. https://doi.org/10.4103/injms.injms_49_23
539. Saifuddin, T. M., Wei, C. W., Ismail, A. F., & Harun, N. A. (2018). Alcohol-Induced Psychotic Disorder with Suicidal Attempt: A Case Report. The Malaysian journal of psychiatry.
540. Saitz, R. (1998). Introduction to alcohol withdrawal.. PubMed.
541. Salama, A. Z., Dabash, M. R., Elayan, A., Saadeh, S., & Ikhmayyes, I. (2024). Dissociative Trance Led to a Catastrophe: A Case Report. Cureus. https://doi.org/10.7759/cureus.76458
542. Samuels, M. (2008). Apparent Life-Threatening Events: Pathogenesis and Management. CRC Press eBooks. https://doi.org/10.3109/9781420060836-15
543. Sanaei‐Zadeh, H. (2016). Toxic Leukoencephalopathy. MOJ Toxicology. https://doi.org/10.15406/mojt.2016.02.00033
544. Sanchis‐Segura, C., & Spanagel, R. (2006). REVIEW: Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addiction Biology. https://doi.org/10.1111/j.1369-1600.2006.00012.x
545. Sandi, C. (2013). Stress and cognition. Wiley Interdisciplinary Reviews Cognitive Science. https://doi.org/10.1002/wcs.1222
546. Sarkar, S., Bhatia, G., & Dhawan, A. (2023). Clinical Practice Guidelines for Assessment and Management of Patients with Substance Intoxication Presenting to the Emergency Department. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_490_22
547. Sarris, J., O’Neil, A., Coulson, C., Schweitzer, I., & Berk, M. (2014). Lifestyle medicine for depression. BMC Psychiatry. https://doi.org/10.1186/1471-244x-14-107
548. Satake, Y., Mamiya, Y., Kano, S., Akizuki, K., Hashimoto, M., & Ikeda, M. (2024). Differential diagnosis and prognosis of delayed neuropsychiatric sequelae after acute carbon monoxide poisoning in a patient with schizophrenia: A case report. Psychiatry and Clinical Neurosciences Reports. https://doi.org/10.1002/pcn5.218
549. Saunders, J. B., Sitharthan, T., & Krabman, P. (2001). An Overview of Substance Use Disorders and Their Management. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_132
550. Sazonov, S. (2014). EPA-0651 – The complexity of psychopathological symptom as a possible indication of mental disease's etiology. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78023-x
551. Scarpino, M., Bonizzoli, M., Lanzi, C., Lanzo, G., Lazzeri, C., Cianchi, G., Gambassi, F., Lolli, F., & Grippo, A. (2020). Brain death following ingestion of E‐cigarette liquid nicotine refill solution. Brain and Behavior. https://doi.org/10.1002/brb3.1744
552. Schaumburg, H. H., Wade, L. O., & Masur, D. (2007). Persistent Psychosis from Toluene Exposure; More Likely Coincidence than Cause: A Review of our Experience and the Literature. Current Psychiatry Reviews. https://doi.org/10.2174/157340007782408842
553. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
554. Schildkrout, B. (2014). Disease #29: Hypoxia (Insufficient Oxygen Supply to the Brain). https://doi.org/10.1002/9781394260447.ch57
555. Schildkrout, B. (2014). Disease #33: Manganese Toxicity. https://doi.org/10.1002/9781394260447.ch61
556. Schildkrout, B. (2014). Disease #34: Mercury Poisoning. https://doi.org/10.1002/9781394260447.ch62
557. Schildkrout, B. (2014). Disease #54: Premenstrual Dysphoric Disorder and Premenstrual Syndrome. https://doi.org/10.1002/9781394260447.ch82
558. Schildkrout, B. (2014). Hallucinations. https://doi.org/10.1002/9781394260447.ch8
559. Schildkrout, B. (2014). Mood, Affect, and Emotion. https://doi.org/10.1002/9781394260447.ch4
560. Schwartzman, R. J. (2006). Common Patterns of Abnormal Sensation. https://doi.org/10.1002/9780470753262.ch8
561. Scotton, W. J., Hill, L. J., Williams, A., & Barnes, N. M. (2019). Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International Journal of Tryptophan Research. https://doi.org/10.1177/1178646919873925
562. Seeman, P., & Seeman, M. V. (2011). Schizophrenia and the supersensitive synapse. Neuropsychiatry. https://doi.org/10.2217/npy.11.18
563. Seetharaman, A., Yadav, P., Adhvaryu, A., & Chatterjee, K. (2024). Psychogenic dysphonia. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_79_23
564. Sejdić, E., Malandraki, G. A., & Coyle, J. L. (2018). Computational Deglutition: Using Signal- and Image-Processing Methods to Understand Swallowing and Associated Disorders [Life Sciences]. IEEE Signal Processing Magazine. https://doi.org/10.1109/msp.2018.2875863
565. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
566. Sengupta, R., Roy, S., & Bhattacharya, M. (2019). STUDY OF GENE-ENVIRONMENT CAUSES OF MAJOR DEPRESSIVE DISORDER TO STATISTICALLY DEFINE THE MOST COMMON CAUSE BEHIND IT.. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/8804
567. Serageldin, M., Hikmet, W., & Alani, S. (2019). Insomnia is a Prodromal Symptom for Psychosis. Journal of the Bahrain Medical Society. https://doi.org/10.26715/jbms.31_31012019
568. Shah, R. R. (2005). Mechanistic basis of adverse drugreactions: the perils of inappropriate dose schedules. Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.4.1.103
569. Shaikh, S., & Lakshmi, R. (2014). Delayed awakening after anaesthesia- A challenge for an anaesthesiologist. International Journal of Biomedical and Advance Research. https://doi.org/10.7439/ijbar.v5i8.829
570. Shams, J., Rahmani, B., Asefi, F., & Daneshfar, S. (2010). CATATONIA DEVELOPMENT IN A SCHIZOAFFECTIVE PATIENT FOLLOWING ELECTROCONVULSIVE THERAPY: CASE REPORT.
571. Sharp, C. W., Rosenberg, N. L., & Beauvais, F. (2008). Substance Abuse: Inhalant‐Related Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch61
572. Sheehy, S. H., Lawrence, T., & Thevathasan, A. W. (2008). Serpentine tongue. Neurology. https://doi.org/10.1212/01.wnl.0000312572.79235.d7
573. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
574. Sherchan, S., & Joshi, D. (2015). The Man Behind the Royal Massacre. Journal of Nepal Medical Association. https://doi.org/10.31729/jnma.2749
575. Shields, L. B. E., Rolf, C. M., & Hunsaker, J. C. (2015). Sudden Death Due To Acute Cocaine Toxicity—Excited Delirium in a Body Packer. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.12860
576. Shprecher, D., & Mehta, L. (2010). The syndrome of delayed post-hypoxic  leukoencephalopathy.. PubMed.
577. Sidana, A., Singh, A., Sawal, N., Chavan, B., & Gupta, R. (2020). Neuropsychiatric manifestations of methyl iodide toxicity. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_638_19
578. Silver, R. M., & Airoldi, J. (2016). 27. Inherited thrombophilia. CRC Press eBooks. https://doi.org/10.1201/9781315200910-28
579. Simbolon, N. Y., Sitorus, T. R., Meliala, T. L., & Waruwu, P. (2020). TINJAUAN KRIMINOLOGI TERHADAP ANAK YANG MELAKUKAN TINDAK PIDANA PENYALAHGUNAAN NARKOTIKA. JURNAL ILMIAH SIMANTEK.
580. Singh, R., Chakravarty, K., Baishya, J., Goyal, M., & Kharbanda, P. (2020). Management of Refractory Epilepsy. International Journal of Epilepsy. https://doi.org/10.1055/s-0040-1712777
581. Slattery, A. P., Liebelt, E. L., & Gaines, L. A. (2014). Common ocular effects reported to a poison control center after systemic absorption of drugs in therapeutic and toxic doses. Current Opinion in Ophthalmology. https://doi.org/10.1097/icu.0000000000000103
582. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
583. Sneep, A., Tjokrodipo, L., & Michielsen, P. (2021). A case of incubus phenomenon. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.2162
584. Soares, E. B., Pires, J. B., Menezes, M. D. A., Santana, S. K. S. D., & Fraga, J. (2010). Fonoaudiologia X ronco/apneia do sono. Revista CEFAC. https://doi.org/10.1590/s1516-18462010000200019
585. Solimini, R., Rotolo, M. C., Pichini, S., & Pacifici, R. (2017). Neurological Disorders in Medical Use of Cannabis: An Update. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527316666170413105421
586. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
587. Soyka, M. (2001). Abuse of, and Dependence on, Medically Prescribed Drugs. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_133
588. Soysal, P., & Işık, A. T. (2014). Hypoactive Delirium Caused by Pulmonary Embolus in an Elderly Adult. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12720
589. Spanagel, R., Tran, B. X., Reyes‐Gibby, C. C., DeBeck, K., Ibrahim, F., & Bonevski, B. (2016). Advances in Drug Addiction.
590. Spiegel, E. P., & Vanderploeg, R. D. (2010). Postconcussion Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0696
591. Sriramoju, M., Keerthi, V. P., Alumdri, D. B., & Akula, S. (2014). Evaluation of antidepressant activity of ethanolic and aqueous extract of Solanum tuberosum peel. Journal of Comprehensive Pharmacy. https://doi.org/10.37483/jcp.2014.1503
592. Stafie, C. S., & Stafie, I. I. (2019). POST COITAL ALLERGY – A CASE REPORT OF POST ORGASMIC ILLNESS SYNDROME. The Medical-Surgical Journal.
593. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
594. Stevens, R. L., Pogrel, M. A., Bosack, R. C., & Orr, T. (2015). Complications with the use of Local Anesthetics. https://doi.org/10.1002/9781119053231.ch31
595. Stewart, J. (2003). Stress and Relapse to Drug Seeking: Studies in Laboratory Animals Shed Light on Mechanisms and Sources of Long‐Term Vulnerability. American Journal on Addictions. https://doi.org/10.1111/j.1521-0391.2003.tb00535.x
596. Stohler, R., Rommelspacher, H., Ladewig, D., & Dammann, G. (1993). [Beta-carbolines (harman/norharman) are increased in heroin dependent patients].. PubMed.
597. Stoller, K. B. (2015). Psychiatric Co-occurring Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214647.003.0015
598. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
599. Summers, C. B. (2007). Cognitive-Behavior Group Therapy in Residential Treatment. https://doi.org/10.4324/9780203941157-16
600. Sussman, S., & Ames, S. L. (2008). Concepts of Cessation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511500039.016
601. Sweet, G., Kim, S., Martin, S. A., Washington, N. B., & Brahm, N. C. (2017). Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians. Mental Health Clinician. https://doi.org/10.9740/mhc.2017.07.156
602. Szyguła‐Jurkiewicz, B., Szymik, M., Mrozowska, B., Schmidt, B., & Michalak, A. (2011). Psychologiczne uwarunkowania i konsekwencje ostrego zawału serca. Leki psychotropowe u chorych po ostrym zawale serca. Choroby Serca i Naczyń.
603. Tacn, A. (2012). PTSD in the Context of Malignant Disease. InTech eBooks. https://doi.org/10.5772/27424
604. Takahashi, A., & Franklin, J. (1996). Alcohol Abuse. Pediatrics in Review. https://doi.org/10.1542/pir.17-2-39
605. Takahashi, A., & Franklin, J. (1996). Alcohol Abuse. Pediatrics in Review. https://doi.org/10.1542/pir.17.2.39
606. Takács, R., Milan, F., Ungvári, G. S., Faludi, G., & Gazdag, G. (2016). Catatonia in disulfiram intoxication - a case report and a brief overview of the literature.. PubMed.
607. Tareen, A., Garralda, M. E., & Hodes, M. (2007). Post-traumatic stress disorder in childhood. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/adc.2006.100305
608. Tedyanto, E. H., Adnyana, I. M. O., & Widyadharma, I. P. E. (2023). Tension-type Headache and Migraine as Manifestations of Chronic Post-Traumatic Headache. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v50i2.528
609. Thomas, N., & Pantelis, C. (2015). Psychotic Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp535
610. Thompson, A., & Weber, A. (2021). Alcohol and Drug Withdrawal Syndromes and Their Clinical Management. DeckerMed Family Medicine. https://doi.org/10.2310/fm.13043
611. Thompson, A., & Weber, A. (2021). Alcohol and Drug Withdrawal Syndromes and Their Clinical Management. https://doi.org/10.2310/cannabis.13043
612. Thompson, A., & Weber, A. (2021). Alcohol and Drug Withdrawal Syndromes and Their Clinical Management. https://doi.org/10.2310/psych.13043
613. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
614. Tickner, N., Apps, J., Keady, S., & Sutcliffe, A. (2012). An overview of drug therapies used in the treatment of dystonia and spasticity in children. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/archdischild-2011-301170
615. Tidey, J. W., & Williams, J. M. (2007). Clinical Indices of Tobacco Use in People with Schizophrenia. Journal of Dual Diagnosis. https://doi.org/10.1300/j374v03n03_07
616. Tiscione, N. B., & Rohrig, T. P. (2021). 1,1-Difluoroethane Forensic Aspects for the Toxicologist and Pathologist. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkab054
617. Todd, O., & Teale, E. (2017). Delirium: a guide for the general physician. Clinical Medicine. https://doi.org/10.7861/clinmedicine.17-1-48
618. Todorović, S. (2016). Socijalno medicinske karakteristike i razlike između alkoholičara sa periodičnim i kontinuiranim pijenjem / Social and Medical Characteristics and Differences Between Alcoholics With Periodic and Continuous Drinking. SESTRINSKI ŽURNAL. https://doi.org/10.7251/sez0116005t
619. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
620. Toom, K., Braschinsky, M., Obermann, M., & Katsarava, Z. (2020). Secondary headache attributed to exposure to or overuse of a substance. Cephalalgia. https://doi.org/10.1177/0333102420942238
621. Torpy, J. M. (2008). Delirium. JAMA. https://doi.org/10.1001/jama.300.24.2936
622. Touze, M.-D., Potel, G., & Baron, D. (1993). [Acute ethyl alcohol intoxication].. PubMed.
623. Trevisan, L., Boutros, N. N., Petrakis, I. L., & Krystal, J. H. (1998). Complications of alcohol withdrawal: pathophysiological insights.. PubMed.
624. Trujillo, K. A. (2002). The Role of NMDA Receptors in Opiate Tolerance, Sensitization, and Physical Dependence. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-306-4_20
625. Tsai, W.-K., Hsia, T., Hang, L., Lee, J., Hsiaw, W.-Y., Shih, C., & Hsu, W. (2005). Successful Treatment of Delayed Neuropsychiatric Sequelae in a Carbon Monoxide Intoxication Patient Using Hyperbaric Oxygen-A Case Report and Literature Review. 胸腔醫學. https://doi.org/10.29806/tm.200510.0012
626. Tsara, V., Amfilochiou, A., Papagrigorakis, J. M., Georgopoulos, D., Liolios, E., Kadiths, A., Koudoumnakis, E., Aulonitou, E., Emporiadou, M., Tsakanikos, M., Chatzis, A. C., Choulakis, M., & Chrousos, G. P. (2010). Guidelines for diagnosing and treating sleep related breathing disorders in adults and children (Part 3: obstructive sleep apnea in children, diagnosis and treatment).. PubMed.
627. Tseng, Y., Wellman, S. E., & Ho, I. (2020). Sedative-Hypnotics: Addiction and Current Research Status. Journal of Food and Drug Analysis. https://doi.org/10.38212/2224-6614.3068
628. Turki, T. (2002). The Emergence of Agitation and Suicide Ideation Secondary to the use of Fluoxetine Therapy: A Case Report. Journal of King Abdulaziz University-Medical Sciences. https://doi.org/10.4197/med.10-1.12
629. Turki, T. A. A., & Arabia, S. (2002). The Emergence of Agitation and Suicide Ideation Secondary to the use of Fluoxetine Therapy: A Case Report.
630. Umut, G., Küçükparlak, İ., Özgen, G., & Türkcan, A. (2011). Esrar Kullanımı Sırasında Başlayan ve N, N- Dimetiltriptamin (Dmt) Kullanımı ile Psikotik Özellikler Eklenen Duygudurum Bozukluğu: Bir Olgu Sunumu / A Mood Disorder Episode with an Onset Under Chronic Cannabis Consumption, and Accompanied With Psychotic Features Immediately After N,N-Dimethyltryptamine (Dmt) Use: A Case Report. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.5350/dajpn2011240312
631. Unknown (2019). Encephalopathy. Definitions. https://doi.org/10.32388/476507
632. Unknown (2019). Epilepsy. Definitions. https://doi.org/10.32388/025983
633. Unknown (2019). Essential Tremor. Definitions. https://doi.org/10.32388/625720
634. Unknown (2019). Hypersomnia. Definitions. https://doi.org/10.32388/969498
635. Unknown (2019). Late-Onset Manic Episode after Bariatric Surgery. International Journal of Psychiatry. https://doi.org/10.33140/ijp.04.01.6
636. Unknown (2019). Traumatic Brain Injury. Definitions. https://doi.org/10.32388/973439
637. Upadhyay, S., Elmatite, W., Taqi, S., Jagia, M., & Mallick, P. (2011). Dexmedetomidine infusion to facilitate opioid detoxification and withdrawal in a patient with chronic opioid abuse. Indian Journal of Palliative Care. https://doi.org/10.4103/0973-1075.92353
638. Urakov, T., & Hart, R. (2017). Intoxicants. Routledge eBooks. https://doi.org/10.4324/9781315382760-68
639. Ushe, M., & Perlmutter, J. S. (2012). I Cannot Eat, Even Though I Want To: An Illustrative Case From Mr A on the Consequences of Dystonia. Movement Disorders. https://doi.org/10.1891/9781617050589.0063
640. Vargas, J. K. R. F. (1999). Artículos de Revisión.
641. Vasconcelos, L. P. B., Gandini, J., Teixeira, A., & Manto, M. (2022). Movement Disorders Associated With Stimulants and Other Drugs of Abuse. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574317.003.0009
642. Velasco-Rey, M. C., Sánchez-Muñoz, M., Lopez, M., Trujillo-Borrego, A., & Sánchez-Bonome, L. (2012). Psychotic depression induced by Obstructive Sleep Apnoea Syndrome (OSAS): a case reported.. PubMed.
643. Venkataraman, R., Patodia, S., & Thiriveedhi, R. N. (2023). Thrombocytopenia in the Critically Ill: An Animal with Several Heads. Indian Journal of Critical Care Case Report. https://doi.org/10.5005/jp-journals-11006-0089
644. Ventriglio, A., Gentile, A. J., Baldessarini, R. J., & Bellomo, A. (2015). Early-Life Stress and Psychiatric Disorders: Epidemiology, Neurobiology and Innovative Pharmacological Targets. Current Pharmaceutical Design. https://doi.org/10.2174/1381612821666150105121244
645. Vergauwen, K. (2024). Physical activity, participation and health-related quality of life in chronic fatigue syndrome and multiple osteochondromas. https://doi.org/10.26481/dis.20240425kv
646. Verhagen, E. H., Hesselmann, G. M., Besse, T. C., & Graeff, A. D. (2005). [Palliative sedation].. PubMed.
647. Verhoeff, M. C., Baat, C. D., Ahlberg, J., Manfredini, D., Winocur, E., Zweers, P. G., Rozema, F. R., Vissink, A., & Lobbezoo, F. (2020). Medications and addictive substances potentially inducing or attenuating sleep bruxism and/or awake bruxism. Journal of Oral Rehabilitation. https://doi.org/10.1111/joor.13061
648. Vernier, L., Rocha, B., Razzolini, D., Bartz, D., & Vargas, G. (2014). Reports of Complaints with Tinnitus Patients: A Qualitative Study. International Archives of Otorhinolaryngology. https://doi.org/10.1055/s-0034-1389005
649. Vilke, G. M., & Ly, B. T. (2022). Clinical Syndromes and Emergency Room Physician and Management Issues. CRC Press eBooks. https://doi.org/10.4324/9781315155159-1
650. Virmani, A., Ali, S. F., & Binienda, Z. (2010). Neuroprotective strategies in drug abuse‐evoked encephalopathy. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2009.05171.x
651. Vivanco, E. F., Gómez, C. P., & Martínez, R. G. (2006). Patología orgànica por drogas de síntesis. Adicciones.
652. Wahyuningsih, S., Nurun, N., Ainul, A., Rendra, R., & Dwiki, D. (2020). Relaksasi Nafas Dalam Terhadap Tingkat Kecemasan Pada Lansia Yang Menderita Hipertensi Di RT 03 RW 09 Kelurahan Slipi Palmerah Jakarta Barat. JURNAL KREATIVITAS PENGABDIAN KEPADA MASYARAKAT (PKM). https://doi.org/10.33024/jkpm.v3i2.3194
653. Wakefield, J. C. (2015). DSM-5 substance use disorder: how conceptual missteps weakened the foundations of the addictive disorders field. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12446
654. Walker, M. C. (2020). Narcolepsy. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0576
655. Walther, M., & Woods, D. W. (2010). Trichotillomania. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1011
656. Wand, G. S. (2008). The influence of stress on the transition from drug use to addiction.. PubMed.
657. Wang, S. (2001). Analysis on the 30 Cases of the Mental Barriers Caused by Taking Some Anti-psychosis Drugs. Journal of Inner Mongolia University for Nationalities.
658. Ward, D. L., MacNeill, A., Grennan, D. M., & Dick, W. C. (1976). Psychiatric Problems in Systemic Lupus Erythematosus. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.128.5.442
659. Weaver, M. F., Heads, A. M., & Faillace, L. A. (2024). Mood Disorders and Comorbid Substance Use Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781108973922.013
660. Weigel, G. (2014). Critical Additions Required. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0488b
661. Weiss, B., Clarkson, T. W., & Simon, W. (2002). Silent latency periods in methylmercury poisoning and in neurodegenerative disease.. Environmental Health Perspectives. https://doi.org/10.1289/ehp.02110s5851
662. Wenbing, C., Asano, T., Notaka, I., Shin-Ichi, M., & Nitta, A. (2025). SUPPRESSION OF TENEURIN-4 IN THE NUCLEUS ACCUMBENS ALLEVIATES METHAMPHETAMINE-INDUCED DOPAMINE RELEASE AND BEHAVIORAL ALTERATIONS IN MICE. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae059.174
663. White, R. J. (1960). Neuropathologic Review of Brain Lesions and Inherent Dangers in Chemopallidectomy. A M A Archives of Neurology. https://doi.org/10.1001/archneur.1960.03840070014002
664. Willner, P. (1984). Drugs, Biochemistry, and Conscious Experience: Toward a Theory of Psychopharmacology. Perspectives in biology and medicine. https://doi.org/10.1353/pbm.1984.0009
665. Wilson, B. A. (1998). Patients and their Problems. https://doi.org/10.1093/oso/9780195065985.003.0001
666. Wilson, K. C., & Saukkonen, J. (2004). Acute Respiratory Failure from Abused Substances. Journal of Intensive Care Medicine. https://doi.org/10.1177/0885066604263918
667. Winbigler, B. L., & Chyka, P. A. (2022). Chapter 43: Substance Misuse and Toxicology. The American Pharmacists Association eBooks. https://doi.org/10.21019/9781582123615.ch43
668. Wing, Y. K., & Leung, C. M. (2012). Mental health impact of severe acute respiratory syndrome: a prospective study.. PubMed.
669. Winters, K. C., & Ingwalson, A. (2022). Internalizing and Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0006
670. Winters, K. C., & Ingwalson, A. (2022). Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0005
671. Winters, W. D. (1976). Effects of Drugs on the Electrical Activity of the Brain: Anesthetics. The Annual Review of Pharmacology and Toxicology. https://doi.org/10.1146/annurev.pa.16.040176.002213
672. Woo, S., & Keatinge, C. (2016). Neurodevelopmental Disorders I: Autism Spectrum Disorder. https://doi.org/10.1002/9781394259472.ch4
673. Wood, A. J., & Welch, K. (1993). Drug Therapy of Migraine. New England Journal of Medicine. https://doi.org/10.1056/nejm199311113292008
674. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
675. Xu, S.-Y., Li, Z.-X., Wu, X., Li, L., & Li, C. (2020). Frequency and Pathophysiology of Post-Seizure Todd’s Paralysis. Medical Science Monitor. https://doi.org/10.12659/msm.920751
676. Yarlagadda, A. R., Brown, A. B., & Clayton, A. H. (2007). Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611h
677. Yates, S. J., Ahuja, N., Gartside, S. E., & McAllister‐Williams, R. H. (2011). Serotonin syndrome following introduction of venlafaxine following withdrawal of phenelzine: implications for drug washout periods. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125311413497
678. Yennurajalingam, S., & Bruera, É. (2015). Fatigue and asthenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199656097.003.0081
679. Yersin, B. (1999). [Ambulatory management of alcohol withdrawal syndrome].. PubMed.
680. Yohannes, A. M., & Baldwin, R. (2008). Medical Comorbidities in Late-Life Depression.
681. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
682. Yudofsky, S. C., Silver, J., & Anderson, K. (2013). Aggressive Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da10
683. Yui, K., Kajii, Y., & Nishikawa, T. (2006). Neurobiological and Molecular Bases of Methamphetamine-Induced Behavioral Sensitization and Spontaneous Recurrence of Methamphetamine Psychosis, and its Implication in Schizophrenia. Current Psychiatry Reviews. https://doi.org/10.2174/157340006778018111
684. Yustiana, A. V., & Aryani, L. N. A. (2019). Gangguan psikotik akibat penggunaan ganja (cannabis): studi kasus. Medicina Journal. https://doi.org/10.15562/medicina.v50i2.123
685. Yüksel, Y., Onultan, O., & Berber, M. (2008). Nonconvulsive status epilepticus during childhood: clinical and electroencephalographic features.. PubMed.
686. Zelaya, J. E., & Al-Khoury, L. (2021). Posterior Reversible Encephalopathy Syndrome.
687. Zhu, X., Zhang, J., & Li, M. (2012). [Decreased sound tolerance and tinnitus].. PubMed.
688. Zhu, Y., Han, G., & Li, S. (2019). Chronic Fatigue Stress and Sudden Death. IntechOpen eBooks. https://doi.org/10.5772/intechopen.88649
689. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c
690. Şenel, G. B., & Karadeniz, D. (2022). Neuroanatomical and Etiological Approaches to Secondary Narcolepsy. Neurological Sciences and Neurophysiology. https://doi.org/10.4103/nsn.nsn_5_22
691. Оstroumova, Т. М., Kulikova, M., & De, V. (2022). Drug-induced hypertension. Medical alphabet. https://doi.org/10.33667/2078-5631-2022-3-8-13